Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union

Identifieur interne : 000B08 ( Pmc/Corpus ); précédent : 000B07; suivant : 000B09

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union

Auteurs : Jürgen Rehm ; Peter Anderson ; Jose Angel Arbesu Prieto ; Iain Armstrong ; Henri-Jean Aubin ; Michael Bachmann ; Nuria Bastida Bastus ; Carlos Brotons ; Robyn Burton ; Manuel Cardoso ; Joan Colom ; Daniel Duprez ; Gerrit Gmel ; Antoni Gual ; Ludwig Kraus ; Reinhold Kreutz ; Helena Liira ; Jakob Manthey ; Lars M Ller ; Ubomír Okruhlica ; Michael Roerecke ; Emanuele Scafato ; Bernd Schulte ; Lidia Segura-Garcia ; Kevin David Shield ; Cristina Sierra ; Konstantin Vyshinskiy ; Marcin Wojnar ; José Zarco

Source :

RBID : PMC:5618725

Abstract

Background

Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.

Methods

A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.

Results

Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.

Conclusions

The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.

Electronic supplementary material

The online version of this article (doi:10.1186/s12916-017-0934-1) contains supplementary material, which is available to authorized users.


Url:
DOI: 10.1186/s12916-017-0934-1
PubMed: 28954635
PubMed Central: 5618725

Links to Exploration step

PMC:5618725

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union</title>
<author>
<name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Addiction Policy, Dalla Lana School of Public Health,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Institute of Medical Science, University of Toronto, Faculty of Medicine,</institution>
</institution-wrap>
Medical Sciences Building, Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff5">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff6">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id>
<institution-id institution-id-type="GRID">grid.4488.0</institution-id>
<institution>Institute of Clinical Psychology and Psychotherapy,</institution>
<institution>Technische Universität Dresden,</institution>
</institution-wrap>
Dresden, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Peter" sort="Anderson, Peter" uniqKey="Anderson P" first="Peter" last="Anderson">Peter Anderson</name>
<affiliation>
<nlm:aff id="Aff7">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0462 7212</institution-id>
<institution-id institution-id-type="GRID">grid.1006.7</institution-id>
<institution>Substance Use, Policy and Practice, Institute of Health and Society,</institution>
<institution>Newcastle University,</institution>
</institution-wrap>
Newcastle upon Tyne, UK</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff8">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id>
<institution-id institution-id-type="GRID">grid.5012.6</institution-id>
<institution>Alcohol and Health, Faculty of Health, Medicine and Life Sciences,</institution>
<institution>Maastricht University,</institution>
</institution-wrap>
Maastricht, Netherlands</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Prieto, Jose Angel Arbesu" sort="Prieto, Jose Angel Arbesu" uniqKey="Prieto J" first="Jose Angel Arbesu" last="Prieto">Jose Angel Arbesu Prieto</name>
<affiliation>
<nlm:aff id="Aff9">Primary Care Center La Eria, Oviedo, Spain</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff10">Primary Care Spanish Society SEMERGEN, Madrid, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Armstrong, Iain" sort="Armstrong, Iain" uniqKey="Armstrong I" first="Iain" last="Armstrong">Iain Armstrong</name>
<affiliation>
<nlm:aff id="Aff11">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id>
<institution-id institution-id-type="GRID">grid.9004.d</institution-id>
<institution>Health and Wellbeing Directorate, Public Health England,</institution>
</institution-wrap>
London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aubin, Henri Jean" sort="Aubin, Henri Jean" uniqKey="Aubin H" first="Henri-Jean" last="Aubin">Henri-Jean Aubin</name>
<affiliation>
<nlm:aff id="Aff12">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0638 6872</institution-id>
<institution-id institution-id-type="GRID">grid.463845.8</institution-id>
<institution>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud,</institution>
</institution-wrap>
Villejuif, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bachmann, Michael" sort="Bachmann, Michael" uniqKey="Bachmann M" first="Michael" last="Bachmann">Michael Bachmann</name>
<affiliation>
<nlm:aff id="Aff13">Copentown Healthcare Consultants, Cape Town, South Africa</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bastus, Nuria Bastida" sort="Bastus, Nuria Bastida" uniqKey="Bastus N" first="Nuria Bastida" last="Bastus">Nuria Bastida Bastus</name>
<affiliation>
<nlm:aff id="Aff14">Primary Health Center, Raval Nord, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brotons, Carlos" sort="Brotons, Carlos" uniqKey="Brotons C" first="Carlos" last="Brotons">Carlos Brotons</name>
<affiliation>
<nlm:aff id="Aff15">Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Burton, Robyn" sort="Burton, Robyn" uniqKey="Burton R" first="Robyn" last="Burton">Robyn Burton</name>
<affiliation>
<nlm:aff id="Aff11">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id>
<institution-id institution-id-type="GRID">grid.9004.d</institution-id>
<institution>Health and Wellbeing Directorate, Public Health England,</institution>
</institution-wrap>
London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cardoso, Manuel" sort="Cardoso, Manuel" uniqKey="Cardoso M" first="Manuel" last="Cardoso">Manuel Cardoso</name>
<affiliation>
<nlm:aff id="Aff16">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.435474.5</institution-id>
<institution>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD),</institution>
</institution-wrap>
Lisbon, Portugal</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Colom, Joan" sort="Colom, Joan" uniqKey="Colom J" first="Joan" last="Colom">Joan Colom</name>
<affiliation>
<nlm:aff id="Aff17">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000123317762</institution-id>
<institution-id institution-id-type="GRID">grid.454735.4</institution-id>
<institution>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Duprez, Daniel" sort="Duprez, Daniel" uniqKey="Duprez D" first="Daniel" last="Duprez">Daniel Duprez</name>
<affiliation>
<nlm:aff id="Aff18">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000419368657</institution-id>
<institution-id institution-id-type="GRID">grid.17635.36</institution-id>
<institution>Cardiovascular Division, School of Medicine,</institution>
<institution>University of Minnesota,</institution>
</institution-wrap>
Minneapolis, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gmel, Gerrit" sort="Gmel, Gerrit" uniqKey="Gmel G" first="Gerrit" last="Gmel">Gerrit Gmel</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff19">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0423 7072</institution-id>
<institution-id institution-id-type="GRID">grid.425461.0</institution-id>
<institution>Implant Systems Group, National ICT Australia,</institution>
</institution-wrap>
Eveleigh, Australia</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff20">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 4902 0432</institution-id>
<institution-id institution-id-type="GRID">grid.1005.4</institution-id>
<institution>Faculty of Engineering,</institution>
<institution>University of New South Wales,</institution>
</institution-wrap>
Sydney, Australia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gual, Antoni" sort="Gual, Antoni" uniqKey="Gual A" first="Antoni" last="Gual">Antoni Gual</name>
<affiliation>
<nlm:aff id="Aff21">Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kraus, Ludwig" sort="Kraus, Ludwig" uniqKey="Kraus L" first="Ludwig" last="Kraus">Ludwig Kraus</name>
<affiliation>
<nlm:aff id="Aff22">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1017 4547</institution-id>
<institution-id institution-id-type="GRID">grid.417840.e</institution-id>
<institution>IFT Institut für Therapieforschung,</institution>
</institution-wrap>
Munich, Germany</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff23">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 9377</institution-id>
<institution-id institution-id-type="GRID">grid.10548.38</institution-id>
<institution>Centre for Social Research on Alcohol and Drugs (SoRAD),</institution>
<institution>Stockholm University,</institution>
</institution-wrap>
Stockholm, Sweden</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kreutz, Reinhold" sort="Kreutz, Reinhold" uniqKey="Kreutz R" first="Reinhold" last="Kreutz">Reinhold Kreutz</name>
<affiliation>
<nlm:aff id="Aff24">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id>
<institution-id institution-id-type="GRID">grid.6363.0</institution-id>
<institution>Institute of Clinical Pharmacology and Toxicology,</institution>
<institution>Charité - Universitätsmedizin Berlin,</institution>
</institution-wrap>
Berlin, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liira, Helena" sort="Liira, Helena" uniqKey="Liira H" first="Helena" last="Liira">Helena Liira</name>
<affiliation>
<nlm:aff id="Aff25">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 7910</institution-id>
<institution-id institution-id-type="GRID">grid.1012.2</institution-id>
<institution>General Practice, School of Primary, Aboriginal and Rural Health Care,</institution>
<institution>University of Western Australia,</institution>
</institution-wrap>
Perth, Australia</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff26">University of Helsinki, Department of General Practice, and Helsinki University Central Hospital, Unit of Primary Health Care, Helsinki, Finland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Manthey, Jakob" sort="Manthey, Jakob" uniqKey="Manthey J" first="Jakob" last="Manthey">Jakob Manthey</name>
<affiliation>
<nlm:aff id="Aff6">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id>
<institution-id institution-id-type="GRID">grid.4488.0</institution-id>
<institution>Institute of Clinical Psychology and Psychotherapy,</institution>
<institution>Technische Universität Dresden,</institution>
</institution-wrap>
Dresden, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="M Ller, Lars" sort="M Ller, Lars" uniqKey="M Ller L" first="Lars" last="M Ller">Lars M Ller</name>
<affiliation>
<nlm:aff id="Aff27">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1939 8248</institution-id>
<institution-id institution-id-type="GRID">grid.420226.0</institution-id>
<institution>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe,</institution>
</institution-wrap>
Copenhagen, Denmark</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Okruhlica, Ubomir" sort="Okruhlica, Ubomir" uniqKey="Okruhlica " first=" Ubomír" last="Okruhlica"> Ubomír Okruhlica</name>
<affiliation>
<nlm:aff id="Aff28">Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Roerecke, Michael" sort="Roerecke, Michael" uniqKey="Roerecke M" first="Michael" last="Roerecke">Michael Roerecke</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Addiction Policy, Dalla Lana School of Public Health,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Scafato, Emanuele" sort="Scafato, Emanuele" uniqKey="Scafato E" first="Emanuele" last="Scafato">Emanuele Scafato</name>
<affiliation>
<nlm:aff id="Aff29">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 9120 6856</institution-id>
<institution-id institution-id-type="GRID">grid.416651.1</institution-id>
<institution>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità,</institution>
</institution-wrap>
Rome, Italy</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff30">Società Italiana di Alcologia (SIA), Italian Society of Alcohology, Bologna, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Schulte, Bernd" sort="Schulte, Bernd" uniqKey="Schulte B" first="Bernd" last="Schulte">Bernd Schulte</name>
<affiliation>
<nlm:aff id="Aff31">Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Segura Garcia, Lidia" sort="Segura Garcia, Lidia" uniqKey="Segura Garcia L" first="Lidia" last="Segura-Garcia">Lidia Segura-Garcia</name>
<affiliation>
<nlm:aff id="Aff17">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000123317762</institution-id>
<institution-id institution-id-type="GRID">grid.454735.4</institution-id>
<institution>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shield, Kevin David" sort="Shield, Kevin David" uniqKey="Shield K" first="Kevin David" last="Shield">Kevin David Shield</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sierra, Cristina" sort="Sierra, Cristina" uniqKey="Sierra C" first="Cristina" last="Sierra">Cristina Sierra</name>
<affiliation>
<nlm:aff id="Aff32">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id>
<institution-id institution-id-type="GRID">grid.5841.8</institution-id>
<institution>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS,</institution>
<institution>University of Barcelona,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vyshinskiy, Konstantin" sort="Vyshinskiy, Konstantin" uniqKey="Vyshinskiy K" first="Konstantin" last="Vyshinskiy">Konstantin Vyshinskiy</name>
<affiliation>
<nlm:aff id="Aff33">Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wojnar, Marcin" sort="Wojnar, Marcin" uniqKey="Wojnar M" first="Marcin" last="Wojnar">Marcin Wojnar</name>
<affiliation>
<nlm:aff id="Aff34">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000113287408</institution-id>
<institution-id institution-id-type="GRID">grid.13339.3b</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>Medical University of Warsaw,</institution>
</institution-wrap>
Warsaw, Poland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zarco, Jose" sort="Zarco, Jose" uniqKey="Zarco J" first="José" last="Zarco">José Zarco</name>
<affiliation>
<nlm:aff id="Aff35">Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">28954635</idno>
<idno type="pmc">5618725</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618725</idno>
<idno type="RBID">PMC:5618725</idno>
<idno type="doi">10.1186/s12916-017-0934-1</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000B08</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B08</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union</title>
<author>
<name sortKey="Rehm, Jurgen" sort="Rehm, Jurgen" uniqKey="Rehm J" first="Jürgen" last="Rehm">Jürgen Rehm</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Addiction Policy, Dalla Lana School of Public Health,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff4">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Institute of Medical Science, University of Toronto, Faculty of Medicine,</institution>
</institution-wrap>
Medical Sciences Building, Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff5">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff6">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id>
<institution-id institution-id-type="GRID">grid.4488.0</institution-id>
<institution>Institute of Clinical Psychology and Psychotherapy,</institution>
<institution>Technische Universität Dresden,</institution>
</institution-wrap>
Dresden, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Peter" sort="Anderson, Peter" uniqKey="Anderson P" first="Peter" last="Anderson">Peter Anderson</name>
<affiliation>
<nlm:aff id="Aff7">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0462 7212</institution-id>
<institution-id institution-id-type="GRID">grid.1006.7</institution-id>
<institution>Substance Use, Policy and Practice, Institute of Health and Society,</institution>
<institution>Newcastle University,</institution>
</institution-wrap>
Newcastle upon Tyne, UK</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff8">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id>
<institution-id institution-id-type="GRID">grid.5012.6</institution-id>
<institution>Alcohol and Health, Faculty of Health, Medicine and Life Sciences,</institution>
<institution>Maastricht University,</institution>
</institution-wrap>
Maastricht, Netherlands</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Prieto, Jose Angel Arbesu" sort="Prieto, Jose Angel Arbesu" uniqKey="Prieto J" first="Jose Angel Arbesu" last="Prieto">Jose Angel Arbesu Prieto</name>
<affiliation>
<nlm:aff id="Aff9">Primary Care Center La Eria, Oviedo, Spain</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff10">Primary Care Spanish Society SEMERGEN, Madrid, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Armstrong, Iain" sort="Armstrong, Iain" uniqKey="Armstrong I" first="Iain" last="Armstrong">Iain Armstrong</name>
<affiliation>
<nlm:aff id="Aff11">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id>
<institution-id institution-id-type="GRID">grid.9004.d</institution-id>
<institution>Health and Wellbeing Directorate, Public Health England,</institution>
</institution-wrap>
London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Aubin, Henri Jean" sort="Aubin, Henri Jean" uniqKey="Aubin H" first="Henri-Jean" last="Aubin">Henri-Jean Aubin</name>
<affiliation>
<nlm:aff id="Aff12">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0638 6872</institution-id>
<institution-id institution-id-type="GRID">grid.463845.8</institution-id>
<institution>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud,</institution>
</institution-wrap>
Villejuif, France</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bachmann, Michael" sort="Bachmann, Michael" uniqKey="Bachmann M" first="Michael" last="Bachmann">Michael Bachmann</name>
<affiliation>
<nlm:aff id="Aff13">Copentown Healthcare Consultants, Cape Town, South Africa</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bastus, Nuria Bastida" sort="Bastus, Nuria Bastida" uniqKey="Bastus N" first="Nuria Bastida" last="Bastus">Nuria Bastida Bastus</name>
<affiliation>
<nlm:aff id="Aff14">Primary Health Center, Raval Nord, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brotons, Carlos" sort="Brotons, Carlos" uniqKey="Brotons C" first="Carlos" last="Brotons">Carlos Brotons</name>
<affiliation>
<nlm:aff id="Aff15">Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Burton, Robyn" sort="Burton, Robyn" uniqKey="Burton R" first="Robyn" last="Burton">Robyn Burton</name>
<affiliation>
<nlm:aff id="Aff11">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id>
<institution-id institution-id-type="GRID">grid.9004.d</institution-id>
<institution>Health and Wellbeing Directorate, Public Health England,</institution>
</institution-wrap>
London, UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cardoso, Manuel" sort="Cardoso, Manuel" uniqKey="Cardoso M" first="Manuel" last="Cardoso">Manuel Cardoso</name>
<affiliation>
<nlm:aff id="Aff16">
<institution-wrap>
<institution-id institution-id-type="GRID">grid.435474.5</institution-id>
<institution>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD),</institution>
</institution-wrap>
Lisbon, Portugal</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Colom, Joan" sort="Colom, Joan" uniqKey="Colom J" first="Joan" last="Colom">Joan Colom</name>
<affiliation>
<nlm:aff id="Aff17">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000123317762</institution-id>
<institution-id institution-id-type="GRID">grid.454735.4</institution-id>
<institution>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Duprez, Daniel" sort="Duprez, Daniel" uniqKey="Duprez D" first="Daniel" last="Duprez">Daniel Duprez</name>
<affiliation>
<nlm:aff id="Aff18">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000419368657</institution-id>
<institution-id institution-id-type="GRID">grid.17635.36</institution-id>
<institution>Cardiovascular Division, School of Medicine,</institution>
<institution>University of Minnesota,</institution>
</institution-wrap>
Minneapolis, USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gmel, Gerrit" sort="Gmel, Gerrit" uniqKey="Gmel G" first="Gerrit" last="Gmel">Gerrit Gmel</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff19">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0423 7072</institution-id>
<institution-id institution-id-type="GRID">grid.425461.0</institution-id>
<institution>Implant Systems Group, National ICT Australia,</institution>
</institution-wrap>
Eveleigh, Australia</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff20">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 4902 0432</institution-id>
<institution-id institution-id-type="GRID">grid.1005.4</institution-id>
<institution>Faculty of Engineering,</institution>
<institution>University of New South Wales,</institution>
</institution-wrap>
Sydney, Australia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gual, Antoni" sort="Gual, Antoni" uniqKey="Gual A" first="Antoni" last="Gual">Antoni Gual</name>
<affiliation>
<nlm:aff id="Aff21">Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kraus, Ludwig" sort="Kraus, Ludwig" uniqKey="Kraus L" first="Ludwig" last="Kraus">Ludwig Kraus</name>
<affiliation>
<nlm:aff id="Aff22">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1017 4547</institution-id>
<institution-id institution-id-type="GRID">grid.417840.e</institution-id>
<institution>IFT Institut für Therapieforschung,</institution>
</institution-wrap>
Munich, Germany</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff23">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 9377</institution-id>
<institution-id institution-id-type="GRID">grid.10548.38</institution-id>
<institution>Centre for Social Research on Alcohol and Drugs (SoRAD),</institution>
<institution>Stockholm University,</institution>
</institution-wrap>
Stockholm, Sweden</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kreutz, Reinhold" sort="Kreutz, Reinhold" uniqKey="Kreutz R" first="Reinhold" last="Kreutz">Reinhold Kreutz</name>
<affiliation>
<nlm:aff id="Aff24">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id>
<institution-id institution-id-type="GRID">grid.6363.0</institution-id>
<institution>Institute of Clinical Pharmacology and Toxicology,</institution>
<institution>Charité - Universitätsmedizin Berlin,</institution>
</institution-wrap>
Berlin, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Liira, Helena" sort="Liira, Helena" uniqKey="Liira H" first="Helena" last="Liira">Helena Liira</name>
<affiliation>
<nlm:aff id="Aff25">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 7910</institution-id>
<institution-id institution-id-type="GRID">grid.1012.2</institution-id>
<institution>General Practice, School of Primary, Aboriginal and Rural Health Care,</institution>
<institution>University of Western Australia,</institution>
</institution-wrap>
Perth, Australia</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff26">University of Helsinki, Department of General Practice, and Helsinki University Central Hospital, Unit of Primary Health Care, Helsinki, Finland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Manthey, Jakob" sort="Manthey, Jakob" uniqKey="Manthey J" first="Jakob" last="Manthey">Jakob Manthey</name>
<affiliation>
<nlm:aff id="Aff6">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id>
<institution-id institution-id-type="GRID">grid.4488.0</institution-id>
<institution>Institute of Clinical Psychology and Psychotherapy,</institution>
<institution>Technische Universität Dresden,</institution>
</institution-wrap>
Dresden, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="M Ller, Lars" sort="M Ller, Lars" uniqKey="M Ller L" first="Lars" last="M Ller">Lars M Ller</name>
<affiliation>
<nlm:aff id="Aff27">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1939 8248</institution-id>
<institution-id institution-id-type="GRID">grid.420226.0</institution-id>
<institution>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe,</institution>
</institution-wrap>
Copenhagen, Denmark</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Okruhlica, Ubomir" sort="Okruhlica, Ubomir" uniqKey="Okruhlica " first=" Ubomír" last="Okruhlica"> Ubomír Okruhlica</name>
<affiliation>
<nlm:aff id="Aff28">Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Roerecke, Michael" sort="Roerecke, Michael" uniqKey="Roerecke M" first="Michael" last="Roerecke">Michael Roerecke</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff2">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff3">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Addiction Policy, Dalla Lana School of Public Health,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Scafato, Emanuele" sort="Scafato, Emanuele" uniqKey="Scafato E" first="Emanuele" last="Scafato">Emanuele Scafato</name>
<affiliation>
<nlm:aff id="Aff29">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 9120 6856</institution-id>
<institution-id institution-id-type="GRID">grid.416651.1</institution-id>
<institution>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità,</institution>
</institution-wrap>
Rome, Italy</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff30">Società Italiana di Alcologia (SIA), Italian Society of Alcohology, Bologna, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Schulte, Bernd" sort="Schulte, Bernd" uniqKey="Schulte B" first="Bernd" last="Schulte">Bernd Schulte</name>
<affiliation>
<nlm:aff id="Aff31">Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Segura Garcia, Lidia" sort="Segura Garcia, Lidia" uniqKey="Segura Garcia L" first="Lidia" last="Segura-Garcia">Lidia Segura-Garcia</name>
<affiliation>
<nlm:aff id="Aff17">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000123317762</institution-id>
<institution-id institution-id-type="GRID">grid.454735.4</institution-id>
<institution>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shield, Kevin David" sort="Shield, Kevin David" uniqKey="Shield K" first="Kevin David" last="Shield">Kevin David Shield</name>
<affiliation>
<nlm:aff id="Aff1">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sierra, Cristina" sort="Sierra, Cristina" uniqKey="Sierra C" first="Cristina" last="Sierra">Cristina Sierra</name>
<affiliation>
<nlm:aff id="Aff32">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id>
<institution-id institution-id-type="GRID">grid.5841.8</institution-id>
<institution>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS,</institution>
<institution>University of Barcelona,</institution>
</institution-wrap>
Barcelona, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vyshinskiy, Konstantin" sort="Vyshinskiy, Konstantin" uniqKey="Vyshinskiy K" first="Konstantin" last="Vyshinskiy">Konstantin Vyshinskiy</name>
<affiliation>
<nlm:aff id="Aff33">Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Wojnar, Marcin" sort="Wojnar, Marcin" uniqKey="Wojnar M" first="Marcin" last="Wojnar">Marcin Wojnar</name>
<affiliation>
<nlm:aff id="Aff34">
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000113287408</institution-id>
<institution-id institution-id-type="GRID">grid.13339.3b</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>Medical University of Warsaw,</institution>
</institution-wrap>
Warsaw, Poland</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Zarco, Jose" sort="Zarco, Jose" uniqKey="Zarco J" first="José" last="Zarco">José Zarco</name>
<affiliation>
<nlm:aff id="Aff35">Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC Medicine</title>
<idno type="eISSN">1741-7015</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background</title>
<p id="Par1">Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12916-017-0934-1) contains supplementary material, which is available to authorized users.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wolf Maier, K" uniqKey="Wolf Maier K">K Wolf-Maier</name>
</author>
<author>
<name sortKey="Cooper, Rs" uniqKey="Cooper R">RS Cooper</name>
</author>
<author>
<name sortKey="Banegas, Jr" uniqKey="Banegas J">JR Banegas</name>
</author>
<author>
<name sortKey="Giampaoli, S" uniqKey="Giampaoli S">S Giampaoli</name>
</author>
<author>
<name sortKey="Hense, Hw" uniqKey="Hense H">HW Hense</name>
</author>
<author>
<name sortKey="Joffres, M" uniqKey="Joffres M">M Joffres</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kontis, V" uniqKey="Kontis V">V Kontis</name>
</author>
<author>
<name sortKey="Mathers, Cd" uniqKey="Mathers C">CD Mathers</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Stevens, Ga" uniqKey="Stevens G">GA Stevens</name>
</author>
<author>
<name sortKey="Shield, Kd" uniqKey="Shield K">KD Shield</name>
</author>
<author>
<name sortKey="Bonita, R" uniqKey="Bonita R">R Bonita</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kontis, V" uniqKey="Kontis V">V Kontis</name>
</author>
<author>
<name sortKey="Mathers, Cd" uniqKey="Mathers C">CD Mathers</name>
</author>
<author>
<name sortKey="Bonita, R" uniqKey="Bonita R">R Bonita</name>
</author>
<author>
<name sortKey="Stevens, Ga" uniqKey="Stevens G">GA Stevens</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Shield, Kd" uniqKey="Shield K">KD Shield</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Chisholm, D" uniqKey="Chisholm D">D Chisholm</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Van Ommeren, M" uniqKey="Van Ommeren M">M van Ommeren</name>
</author>
<author>
<name sortKey="Monteiro, M" uniqKey="Monteiro M">M Monteiro</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Collart, F" uniqKey="Collart F">F Collart</name>
</author>
<author>
<name sortKey="De Timary, P" uniqKey="De Timary P">P de Timary</name>
</author>
<author>
<name sortKey="Dom, G" uniqKey="Dom G">G Dom</name>
</author>
<author>
<name sortKey="Dor, Bd" uniqKey="Dor B">BD Dor</name>
</author>
<author>
<name sortKey="Duprez, D" uniqKey="Duprez D">D Duprez</name>
</author>
<author>
<name sortKey="Lengele, Jp" uniqKey="Lengele J">JP Lengelé</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Aalto, M" uniqKey="Aalto M">M Aalto</name>
</author>
<author>
<name sortKey="Jula, A" uniqKey="Jula A">A Jula</name>
</author>
<author>
<name sortKey="Kein Nen Kiukaanniemi, S" uniqKey="Kein Nen Kiukaanniemi S">S Keinänen-Kiukaanniemi</name>
</author>
<author>
<name sortKey="Liira, H" uniqKey="Liira H">H Liira</name>
</author>
<author>
<name sortKey="R S Nen, K" uniqKey="R S Nen K">K Räsänen</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Gmel, G" uniqKey="Gmel G">G Gmel</name>
</author>
<author>
<name sortKey="Kiefer, F" uniqKey="Kiefer F">F Kiefer</name>
</author>
<author>
<name sortKey="Kreutz, R" uniqKey="Kreutz R">R Kreutz</name>
</author>
<author>
<name sortKey="Kugler, J" uniqKey="Kugler J">J Kugler</name>
</author>
<author>
<name sortKey="Muller Walther, M" uniqKey="Muller Walther M">M Müller-Walther</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Zarco, J" uniqKey="Zarco J">J Zarco</name>
</author>
<author>
<name sortKey="Colom, Jf" uniqKey="Colom J">JF Colom</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stevens, Ga" uniqKey="Stevens G">GA Stevens</name>
</author>
<author>
<name sortKey="Alkema, L" uniqKey="Alkema L">L Alkema</name>
</author>
<author>
<name sortKey="Black, Re" uniqKey="Black R">RE Black</name>
</author>
<author>
<name sortKey="Boerma, Jt" uniqKey="Boerma J">JT Boerma</name>
</author>
<author>
<name sortKey="Collins, Gs" uniqKey="Collins G">GS Collins</name>
</author>
<author>
<name sortKey="Ezzati, M" uniqKey="Ezzati M">M Ezzati</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Angel, J" uniqKey="Angel J">J Angel</name>
</author>
<author>
<name sortKey="Prieto, A" uniqKey="Prieto A">A Prieto</name>
</author>
<author>
<name sortKey="Beier, M" uniqKey="Beier M">M Beier</name>
</author>
<author>
<name sortKey="Duhot, D" uniqKey="Duhot D">D Duhot</name>
</author>
<author>
<name sortKey="Rossi, A" uniqKey="Rossi A">A Rossi</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Taylor, B" uniqKey="Taylor B">B Taylor</name>
</author>
<author>
<name sortKey="Irving, Hm" uniqKey="Irving H">HM Irving</name>
</author>
<author>
<name sortKey="Baliunas, D" uniqKey="Baliunas D">D Baliunas</name>
</author>
<author>
<name sortKey="Roerecke, M" uniqKey="Roerecke M">M Roerecke</name>
</author>
<author>
<name sortKey="Patra, J" uniqKey="Patra J">J Patra</name>
</author>
<author>
<name sortKey="Mohapatra, S" uniqKey="Mohapatra S">S Mohapatra</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Briasoulis, A" uniqKey="Briasoulis A">A Briasoulis</name>
</author>
<author>
<name sortKey="Agarwal, V" uniqKey="Agarwal V">V Agarwal</name>
</author>
<author>
<name sortKey="Messerli, Fh" uniqKey="Messerli F">FH Messerli</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="O Eefe, Jh" uniqKey="O Eefe J">JH O’Keefe</name>
</author>
<author>
<name sortKey="Bhatti, Sk" uniqKey="Bhatti S">SK Bhatti</name>
</author>
<author>
<name sortKey="Bajwa, A" uniqKey="Bajwa A">A Bajwa</name>
</author>
<author>
<name sortKey="Dinicolantonio, Jj" uniqKey="Dinicolantonio J">JJ DiNicolantonio</name>
</author>
<author>
<name sortKey="Lavie, Cj" uniqKey="Lavie C">CJ Lavie</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Puddey, Ib" uniqKey="Puddey I">IB Puddey</name>
</author>
<author>
<name sortKey="Beilin, Lj" uniqKey="Beilin L">LJ Beilin</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Klatsky, Al" uniqKey="Klatsky A">AL Klatsky</name>
</author>
<author>
<name sortKey="Gunderson, E" uniqKey="Gunderson E">E Gunderson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sesso, Hd" uniqKey="Sesso H">HD Sesso</name>
</author>
<author>
<name sortKey="Cook, Nr" uniqKey="Cook N">NR Cook</name>
</author>
<author>
<name sortKey="Buring, Je" uniqKey="Buring J">JE Buring</name>
</author>
<author>
<name sortKey="Manson, Je" uniqKey="Manson J">JE Manson</name>
</author>
<author>
<name sortKey="Gaziano, Jm" uniqKey="Gaziano J">JM Gaziano</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Klatsky, Al" uniqKey="Klatsky A">AL Klatsky</name>
</author>
<author>
<name sortKey="Gundersen, E" uniqKey="Gundersen E">E Gundersen</name>
</author>
<author>
<name sortKey="Kipp, H" uniqKey="Kipp H">H Kipp</name>
</author>
<author>
<name sortKey="Udaltsova, N" uniqKey="Udaltsova N">N Udaltsova</name>
</author>
<author>
<name sortKey="Friedman, Gd" uniqKey="Friedman G">GD Friedman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saunders, Jb" uniqKey="Saunders J">JB Saunders</name>
</author>
<author>
<name sortKey="Paton, A" uniqKey="Paton A">A Paton</name>
</author>
<author>
<name sortKey="Beevers, Dg" uniqKey="Beevers D">DG Beevers</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Allamani, A" uniqKey="Allamani A">A Allamani</name>
</author>
<author>
<name sortKey="Elekes, Z" uniqKey="Elekes Z">Z Elekes</name>
</author>
<author>
<name sortKey="Jakubczyk, A" uniqKey="Jakubczyk A">A Jakubczyk</name>
</author>
<author>
<name sortKey="Landsmane, I" uniqKey="Landsmane I">I Landsmane</name>
</author>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Gmel, Sg" uniqKey="Gmel S">SG Gmel</name>
</author>
<author>
<name sortKey="Gmel, Ge" uniqKey="Gmel G">GE Gmel</name>
</author>
<author>
<name sortKey="Hasan, Osm" uniqKey="Hasan O">OSM Hasan</name>
</author>
<author>
<name sortKey="Imtiaz, S" uniqKey="Imtiaz S">S Imtiaz</name>
</author>
<author>
<name sortKey="Popova, S" uniqKey="Popova S">S Popova</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Saunders, Jb" uniqKey="Saunders J">JB Saunders</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Baliunas, D" uniqKey="Baliunas D">D Baliunas</name>
</author>
<author>
<name sortKey="Borges, Gl" uniqKey="Borges G">GL Borges</name>
</author>
<author>
<name sortKey="Graham, K" uniqKey="Graham K">K Graham</name>
</author>
<author>
<name sortKey="Irving, Hm" uniqKey="Irving H">HM Irving</name>
</author>
<author>
<name sortKey="Kehoe, T" uniqKey="Kehoe T">T Kehoe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xin, X" uniqKey="Xin X">X Xin</name>
</author>
<author>
<name sortKey="He, J" uniqKey="He J">J He</name>
</author>
<author>
<name sortKey="Frontini, Mg" uniqKey="Frontini M">MG Frontini</name>
</author>
<author>
<name sortKey="Ogden, Lg" uniqKey="Ogden L">LG Ogden</name>
</author>
<author>
<name sortKey="Motsamai, Oj" uniqKey="Motsamai O">OJ Motsamai</name>
</author>
<author>
<name sortKey="Whelton, Pk" uniqKey="Whelton P">PK Whelton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Stewart, Sh" uniqKey="Stewart S">SH Stewart</name>
</author>
<author>
<name sortKey="Latham, Pk" uniqKey="Latham P">PK Latham</name>
</author>
<author>
<name sortKey="Miller, Pm" uniqKey="Miller P">PM Miller</name>
</author>
<author>
<name sortKey="Randall, P" uniqKey="Randall P">P Randall</name>
</author>
<author>
<name sortKey="Anton, Rf" uniqKey="Anton R">RF Anton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Roerecke, M" uniqKey="Roerecke M">M Roerecke</name>
</author>
<author>
<name sortKey="Kaczorowski, J" uniqKey="Kaczorowski J">J Kaczorowski</name>
</author>
<author>
<name sortKey="Tobe, Sw" uniqKey="Tobe S">SW Tobe</name>
</author>
<author>
<name sortKey="Gmel, G" uniqKey="Gmel G">G Gmel</name>
</author>
<author>
<name sortKey="Hasan, Osm" uniqKey="Hasan O">OSM Hasan</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Higgins, Jpt" uniqKey="Higgins J">JPT Higgins</name>
</author>
<author>
<name sortKey="Green, S" uniqKey="Green S">S Green</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Patel, Hc" uniqKey="Patel H">HC Patel</name>
</author>
<author>
<name sortKey="Hayward, C" uniqKey="Hayward C">C Hayward</name>
</author>
<author>
<name sortKey="Ozdemir, Ba" uniqKey="Ozdemir B">BA Ozdemir</name>
</author>
<author>
<name sortKey="Rosen, Sd" uniqKey="Rosen S">SD Rosen</name>
</author>
<author>
<name sortKey="Krum, H" uniqKey="Krum H">H Krum</name>
</author>
<author>
<name sortKey="Lyon, Ar" uniqKey="Lyon A">AR Lyon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mancia, G" uniqKey="Mancia G">G Mancia</name>
</author>
<author>
<name sortKey="Fagard, R" uniqKey="Fagard R">R Fagard</name>
</author>
<author>
<name sortKey="Narkiewicz, K" uniqKey="Narkiewicz K">K Narkiewicz</name>
</author>
<author>
<name sortKey="Redon, J" uniqKey="Redon J">J Redon</name>
</author>
<author>
<name sortKey="Zanchetti, A" uniqKey="Zanchetti A">A Zanchetti</name>
</author>
<author>
<name sortKey="Bohm, M" uniqKey="Bohm M">M Bohm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Campbell, Nr" uniqKey="Campbell N">NR Campbell</name>
</author>
<author>
<name sortKey="Ashley, Mj" uniqKey="Ashley M">MJ Ashley</name>
</author>
<author>
<name sortKey="Carruthers, Sg" uniqKey="Carruthers S">SG Carruthers</name>
</author>
<author>
<name sortKey="Lacourciere, Y" uniqKey="Lacourciere Y">Y Lacourcière</name>
</author>
<author>
<name sortKey="Mckay, Dw" uniqKey="Mckay D">DW McKay</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Weber, Ma" uniqKey="Weber M">MA Weber</name>
</author>
<author>
<name sortKey="Schiffrin, El" uniqKey="Schiffrin E">EL Schiffrin</name>
</author>
<author>
<name sortKey="White, Wb" uniqKey="White W">WB White</name>
</author>
<author>
<name sortKey="Mann, S" uniqKey="Mann S">S Mann</name>
</author>
<author>
<name sortKey="Lindholm, Lh" uniqKey="Lindholm L">LH Lindholm</name>
</author>
<author>
<name sortKey="Kenerson, Jg" uniqKey="Kenerson J">JG Kenerson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="James, Pa" uniqKey="James P">PA James</name>
</author>
<author>
<name sortKey="Oparil, S" uniqKey="Oparil S">S Oparil</name>
</author>
<author>
<name sortKey="Carter, Bl" uniqKey="Carter B">BL Carter</name>
</author>
<author>
<name sortKey="Cushman, Wc" uniqKey="Cushman W">WC Cushman</name>
</author>
<author>
<name sortKey="Dennison Himmelfarb, C" uniqKey="Dennison Himmelfarb C">C Dennison-Himmelfarb</name>
</author>
<author>
<name sortKey="Handler, J" uniqKey="Handler J">J Handler</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Eckel, Rh" uniqKey="Eckel R">RH Eckel</name>
</author>
<author>
<name sortKey="Jakicic, Jm" uniqKey="Jakicic J">JM Jakicic</name>
</author>
<author>
<name sortKey="Ard, Jd" uniqKey="Ard J">JD Ard</name>
</author>
<author>
<name sortKey="De Jesus, Jm" uniqKey="De Jesus J">JM de Jesus</name>
</author>
<author>
<name sortKey="Houston Miller, N" uniqKey="Houston Miller N">N Houston Miller</name>
</author>
<author>
<name sortKey="Hubbard, Vs" uniqKey="Hubbard V">VS Hubbard</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Marmet, S" uniqKey="Marmet S">S Marmet</name>
</author>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Kraus, L" uniqKey="Kraus L">L Kraus</name>
</author>
<author>
<name sortKey="Nutt, Dj" uniqKey="Nutt D">DJ Nutt</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Li, Tk" uniqKey="Li T">TK Li</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Klatsky, Al" uniqKey="Klatsky A">AL Klatsky</name>
</author>
<author>
<name sortKey="Koplik, S" uniqKey="Koplik S">S Koplik</name>
</author>
<author>
<name sortKey="Gunderson, E" uniqKey="Gunderson E">E Gunderson</name>
</author>
<author>
<name sortKey="Kipp, H" uniqKey="Kipp H">H Kipp</name>
</author>
<author>
<name sortKey="Friedman, Gd" uniqKey="Friedman G">GD Friedman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Miller, Pm" uniqKey="Miller P">PM Miller</name>
</author>
<author>
<name sortKey="Anton, Rf" uniqKey="Anton R">RF Anton</name>
</author>
<author>
<name sortKey="Egan, Bm" uniqKey="Egan B">BM Egan</name>
</author>
<author>
<name sortKey="Basile, J" uniqKey="Basile J">J Basile</name>
</author>
<author>
<name sortKey="Nguyen, Sa" uniqKey="Nguyen S">SA Nguyen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Jakubczyk, A" uniqKey="Jakubczyk A">A Jakubczyk</name>
</author>
<author>
<name sortKey="Pieper, L" uniqKey="Pieper L">L Pieper</name>
</author>
<author>
<name sortKey="Probst, C" uniqKey="Probst C">C Probst</name>
</author>
<author>
<name sortKey="Struzzo, P" uniqKey="Struzzo P">P Struzzo</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Allamani, A" uniqKey="Allamani A">A Allamani</name>
</author>
<author>
<name sortKey="Elekes, Z" uniqKey="Elekes Z">Z Elekes</name>
</author>
<author>
<name sortKey="Jakubczyk, A" uniqKey="Jakubczyk A">A Jakubczyk</name>
</author>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
<author>
<name sortKey="Probst, P" uniqKey="Probst P">P Probst</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
<author>
<name sortKey="Struzzo, P" uniqKey="Struzzo P">P Struzzo</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Wojnar, M" uniqKey="Wojnar M">M Wojnar</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kaner, Ef" uniqKey="Kaner E">EF Kaner</name>
</author>
<author>
<name sortKey="Beyer, F" uniqKey="Beyer F">F Beyer</name>
</author>
<author>
<name sortKey="Dickinson, Ho" uniqKey="Dickinson H">HO Dickinson</name>
</author>
<author>
<name sortKey="Pienaar, E" uniqKey="Pienaar E">E Pienaar</name>
</author>
<author>
<name sortKey="Campbell, F" uniqKey="Campbell F">F Campbell</name>
</author>
<author>
<name sortKey="Schlesinger, C" uniqKey="Schlesinger C">C Schlesinger</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Miller, Wr" uniqKey="Miller W">WR Miller</name>
</author>
<author>
<name sortKey="Wilbourne, Pl" uniqKey="Wilbourne P">PL Wilbourne</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Martin, G" uniqKey="Martin G">G Martin</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mann, K" uniqKey="Mann K">K Mann</name>
</author>
<author>
<name sortKey="Bladstrom, A" uniqKey="Bladstrom A">A Bladström</name>
</author>
<author>
<name sortKey="Torup, L" uniqKey="Torup L">L Torup</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Van Den Brink, W" uniqKey="Van Den Brink W">W Van den Brink</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="He, Y" uniqKey="He Y">Y He</name>
</author>
<author>
<name sortKey="Torup, L" uniqKey="Torup L">L Torup</name>
</author>
<author>
<name sortKey="Van Den Brink, W" uniqKey="Van Den Brink W">W Van Den Brink</name>
</author>
<author>
<name sortKey="Mann, K" uniqKey="Mann K">K Mann</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Van Den Brink, W" uniqKey="Van Den Brink W">W van den Brink</name>
</author>
<author>
<name sortKey="S Rensen, P" uniqKey="S Rensen P">P Sørensen</name>
</author>
<author>
<name sortKey="Torup, L" uniqKey="Torup L">L Torup</name>
</author>
<author>
<name sortKey="Mann, K" uniqKey="Mann K">K Mann</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kraus, L" uniqKey="Kraus L">L Kraus</name>
</author>
<author>
<name sortKey="Schulte, B" uniqKey="Schulte B">B Schulte</name>
</author>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Bendtsen, P" uniqKey="Bendtsen P">P Bendtsen</name>
</author>
<author>
<name sortKey="Spak, F" uniqKey="Spak F">F Spak</name>
</author>
<author>
<name sortKey="Reynolds, J" uniqKey="Reynolds J">J Reynolds</name>
</author>
<author>
<name sortKey="Drummond, C" uniqKey="Drummond C">C Drummond</name>
</author>
<author>
<name sortKey="Segura, L" uniqKey="Segura L">L Segura</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Johnson, M" uniqKey="Johnson M">M Johnson</name>
</author>
<author>
<name sortKey="Jackson, R" uniqKey="Jackson R">R Jackson</name>
</author>
<author>
<name sortKey="Guillaume, L" uniqKey="Guillaume L">L Guillaume</name>
</author>
<author>
<name sortKey="Meier, P" uniqKey="Meier P">P Meier</name>
</author>
<author>
<name sortKey="Goyder, E" uniqKey="Goyder E">E Goyder</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Wojnar, M" uniqKey="Wojnar M">M Wojnar</name>
</author>
<author>
<name sortKey="Jakubczyk, A" uniqKey="Jakubczyk A">A Jakubczyk</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Segura, L" uniqKey="Segura L">L Segura</name>
</author>
<author>
<name sortKey="Sovinova, H" uniqKey="Sovinova H">H Sovinova</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Swales, Jd" uniqKey="Swales J">JD Swales</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ezzati, M" uniqKey="Ezzati M">M Ezzati</name>
</author>
<author>
<name sortKey="Lopez, A" uniqKey="Lopez A">A Lopez</name>
</author>
<author>
<name sortKey="Rodgers, A" uniqKey="Rodgers A">A Rodgers</name>
</author>
<author>
<name sortKey="Murray, Cjl" uniqKey="Murray C">CJL Murray</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Imtiaz, S" uniqKey="Imtiaz S">S Imtiaz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="O Onnell, A" uniqKey="O Onnell A">A O’Donnell</name>
</author>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Newbury Birch, D" uniqKey="Newbury Birch D">D Newbury-Birch</name>
</author>
<author>
<name sortKey="Schulte, B" uniqKey="Schulte B">B Schulte</name>
</author>
<author>
<name sortKey="Schmidt, C" uniqKey="Schmidt C">C Schmidt</name>
</author>
<author>
<name sortKey="Reimer, J" uniqKey="Reimer J">J Reimer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Patra, J" uniqKey="Patra J">J Patra</name>
</author>
<author>
<name sortKey="Popova, L" uniqKey="Popova L">L Popova</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Holmes, J" uniqKey="Holmes J">J Holmes</name>
</author>
<author>
<name sortKey="Meier, Ps" uniqKey="Meier P">PS Meier</name>
</author>
<author>
<name sortKey="Booth, A" uniqKey="Booth A">A Booth</name>
</author>
<author>
<name sortKey="Guo, Y" uniqKey="Guo Y">Y Guo</name>
</author>
<author>
<name sortKey="Brennan, A" uniqKey="Brennan A">A Brennan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zatonski, W" uniqKey="Zatonski W">W Zatonski</name>
</author>
<author>
<name sortKey="Sulkowska, U" uniqKey="Sulkowska U">U Sulkowska</name>
</author>
<author>
<name sortKey="Manczuk, M" uniqKey="Manczuk M">M Manczuk</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Lowenfels, Ab" uniqKey="Lowenfels A">AB Lowenfels</name>
</author>
<author>
<name sortKey="La Vecchia, C" uniqKey="La Vecchia C">C La Vecchia</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Piper, Ma" uniqKey="Piper M">MA Piper</name>
</author>
<author>
<name sortKey="Evans, Cv" uniqKey="Evans C">CV Evans</name>
</author>
<author>
<name sortKey="Burda, Bu" uniqKey="Burda B">BU Burda</name>
</author>
<author>
<name sortKey="Margolis, Kl" uniqKey="Margolis K">KL Margolis</name>
</author>
<author>
<name sortKey="O Onnor, E" uniqKey="O Onnor E">E O’Connor</name>
</author>
<author>
<name sortKey="Smith, N" uniqKey="Smith N">N Smith</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sheridan, S" uniqKey="Sheridan S">S Sheridan</name>
</author>
<author>
<name sortKey="Pignone, M" uniqKey="Pignone M">M Pignone</name>
</author>
<author>
<name sortKey="Donahue, K" uniqKey="Donahue K">K Donahue</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kaczorowski, J" uniqKey="Kaczorowski J">J Kaczorowski</name>
</author>
<author>
<name sortKey="Chambers, Lw" uniqKey="Chambers L">LW Chambers</name>
</author>
<author>
<name sortKey="Dolovich, L" uniqKey="Dolovich L">L Dolovich</name>
</author>
<author>
<name sortKey="Paterson, Jm" uniqKey="Paterson J">JM Paterson</name>
</author>
<author>
<name sortKey="Karwalajtys, T" uniqKey="Karwalajtys T">T Karwalajtys</name>
</author>
<author>
<name sortKey="Gierman, T" uniqKey="Gierman T">T Gierman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hodgkinson, J" uniqKey="Hodgkinson J">J Hodgkinson</name>
</author>
<author>
<name sortKey="Mant, J" uniqKey="Mant J">J Mant</name>
</author>
<author>
<name sortKey="Martin, U" uniqKey="Martin U">U Martin</name>
</author>
<author>
<name sortKey="Guo, B" uniqKey="Guo B">B Guo</name>
</author>
<author>
<name sortKey="Hobbs, Fd" uniqKey="Hobbs F">FD Hobbs</name>
</author>
<author>
<name sortKey="Deeks, Jj" uniqKey="Deeks J">JJ Deeks</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Day, E" uniqKey="Day E">E Day</name>
</author>
<author>
<name sortKey="Copello, A" uniqKey="Copello A">A Copello</name>
</author>
<author>
<name sortKey="Hull, M" uniqKey="Hull M">M Hull</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Spithoff, S" uniqKey="Spithoff S">S Spithoff</name>
</author>
<author>
<name sortKey="Kahan, M" uniqKey="Kahan M">M Kahan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Manthey, J" uniqKey="Manthey J">J Manthey</name>
</author>
<author>
<name sortKey="Shield, Kd" uniqKey="Shield K">KD Shield</name>
</author>
<author>
<name sortKey="Struzzo, P" uniqKey="Struzzo P">P Struzzo</name>
</author>
<author>
<name sortKey="Wojnar, M" uniqKey="Wojnar M">M Wojnar</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rosner, S" uniqKey="Rosner S">S Rösner</name>
</author>
<author>
<name sortKey="Hackl Herrwerth, A" uniqKey="Hackl Herrwerth A">A Hackl-Herrwerth</name>
</author>
<author>
<name sortKey="Leucht, S" uniqKey="Leucht S">S Leucht</name>
</author>
<author>
<name sortKey="Vecchi, S" uniqKey="Vecchi S">S Vecchi</name>
</author>
<author>
<name sortKey="Srisurapanont, M" uniqKey="Srisurapanont M">M Srisurapanont</name>
</author>
<author>
<name sortKey="Soyka, M" uniqKey="Soyka M">M Soyka</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lee, J" uniqKey="Lee J">J Lee</name>
</author>
<author>
<name sortKey="Kresina, Tf" uniqKey="Kresina T">TF Kresina</name>
</author>
<author>
<name sortKey="Campopiano, M" uniqKey="Campopiano M">M Campopiano</name>
</author>
<author>
<name sortKey="Lubran, R" uniqKey="Lubran R">R Lubran</name>
</author>
<author>
<name sortKey="Clark, Hw" uniqKey="Clark H">HW Clark</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Baros, Am" uniqKey="Baros A">AM Baros</name>
</author>
<author>
<name sortKey="Wright, Tm" uniqKey="Wright T">TM Wright</name>
</author>
<author>
<name sortKey="Latham, Pk" uniqKey="Latham P">PK Latham</name>
</author>
<author>
<name sortKey="Miller, Pm" uniqKey="Miller P">PM Miller</name>
</author>
<author>
<name sortKey="Anton, Rf" uniqKey="Anton R">RF Anton</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Aguilera, Mt" uniqKey="Aguilera M">MT Aguilera</name>
</author>
<author>
<name sortKey="De La Sierra, A" uniqKey="De La Sierra A">A De la Sierra</name>
</author>
<author>
<name sortKey="Coca, A" uniqKey="Coca A">A Coca</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wallace, P" uniqKey="Wallace P">P Wallace</name>
</author>
<author>
<name sortKey="Cutler, S" uniqKey="Cutler S">S Cutler</name>
</author>
<author>
<name sortKey="Haines, A" uniqKey="Haines A">A Haines</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Gual, A" uniqKey="Gual A">A Gual</name>
</author>
<author>
<name sortKey="Kraus, L" uniqKey="Kraus L">L Kraus</name>
</author>
<author>
<name sortKey="Marmet, S" uniqKey="Marmet S">S Marmet</name>
</author>
<author>
<name sortKey="Room, R" uniqKey="Room R">R Room</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sarafidis, Pa" uniqKey="Sarafidis P">PA Sarafidis</name>
</author>
<author>
<name sortKey="Georgianos, P" uniqKey="Georgianos P">P Georgianos</name>
</author>
<author>
<name sortKey="Bakris, Gl" uniqKey="Bakris G">GL Bakris</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Calhoun, Da" uniqKey="Calhoun D">DA Calhoun</name>
</author>
<author>
<name sortKey="Jones, D" uniqKey="Jones D">D Jones</name>
</author>
<author>
<name sortKey="Textor, S" uniqKey="Textor S">S Textor</name>
</author>
<author>
<name sortKey="Goff, Dc" uniqKey="Goff D">DC Goff</name>
</author>
<author>
<name sortKey="Murphy, Tp" uniqKey="Murphy T">TP Murphy</name>
</author>
<author>
<name sortKey="Toto, Rd" uniqKey="Toto R">RD Toto</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Denolle, T" uniqKey="Denolle T">T Denolle</name>
</author>
<author>
<name sortKey="Chamontin, B" uniqKey="Chamontin B">B Chamontin</name>
</author>
<author>
<name sortKey="Doll, G" uniqKey="Doll G">G Doll</name>
</author>
<author>
<name sortKey="Fauvel, Jp" uniqKey="Fauvel J">JP Fauvel</name>
</author>
<author>
<name sortKey="Girerd, X" uniqKey="Girerd X">X Girerd</name>
</author>
<author>
<name sortKey="Herpin, D" uniqKey="Herpin D">D Herpin</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Angus, C" uniqKey="Angus C">C Angus</name>
</author>
<author>
<name sortKey="Latimer, N" uniqKey="Latimer N">N Latimer</name>
</author>
<author>
<name sortKey="Preston, L" uniqKey="Preston L">L Preston</name>
</author>
<author>
<name sortKey="Li, J" uniqKey="Li J">J Li</name>
</author>
<author>
<name sortKey="Purshouse, R" uniqKey="Purshouse R">R Purshouse</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Angus, C" uniqKey="Angus C">C Angus</name>
</author>
<author>
<name sortKey="Thomas, C" uniqKey="Thomas C">C Thomas</name>
</author>
<author>
<name sortKey="Anderson, P" uniqKey="Anderson P">P Anderson</name>
</author>
<author>
<name sortKey="Meier, Ps" uniqKey="Meier P">PS Meier</name>
</author>
<author>
<name sortKey="Brennan, A" uniqKey="Brennan A">A Brennan</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Shield, Kd" uniqKey="Shield K">KD Shield</name>
</author>
<author>
<name sortKey="Rylett, M" uniqKey="Rylett M">M Rylett</name>
</author>
<author>
<name sortKey="Rehm, J" uniqKey="Rehm J">J Rehm</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Drummond, Mf" uniqKey="Drummond M">MF Drummond</name>
</author>
<author>
<name sortKey="Sculpher, Mj" uniqKey="Sculpher M">MJ Sculpher</name>
</author>
<author>
<name sortKey="Torrance, Gw" uniqKey="Torrance G">GW Torrance</name>
</author>
<author>
<name sortKey="O Rien, Bj" uniqKey="O Rien B">BJ O’Brien</name>
</author>
<author>
<name sortKey="Stoddart, Gl" uniqKey="Stoddart G">GL Stoddart</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Banegas, Jr" uniqKey="Banegas J">JR Banegas</name>
</author>
<author>
<name sortKey="Graciani, A" uniqKey="Graciani A">A Graciani</name>
</author>
<author>
<name sortKey="De La Cruz Troca, Jj" uniqKey="De La Cruz Troca J">JJ de la Cruz-Troca</name>
</author>
<author>
<name sortKey="Le N Mu Oz, Lm" uniqKey="Le N Mu Oz L">LM León-Muñoz</name>
</author>
<author>
<name sortKey="Guallar Castill N, P" uniqKey="Guallar Castill N P">P Guallar-Castillón</name>
</author>
<author>
<name sortKey="Coca, A" uniqKey="Coca A">A Coca</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Godet Thobie, H" uniqKey="Godet Thobie H">H Godet-Thobie</name>
</author>
<author>
<name sortKey="Vernay, M" uniqKey="Vernay M">M Vernay</name>
</author>
<author>
<name sortKey="Noukpoape, A" uniqKey="Noukpoape A">A Noukpoape</name>
</author>
<author>
<name sortKey="Salanave, B" uniqKey="Salanave B">B Salanave</name>
</author>
<author>
<name sortKey="Malon, A" uniqKey="Malon A">A Malon</name>
</author>
<author>
<name sortKey="Castebon, K" uniqKey="Castebon K">K Castebon</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Neuhauser, H" uniqKey="Neuhauser H">H Neuhauser</name>
</author>
<author>
<name sortKey="Thamm, M" uniqKey="Thamm M">M Thamm</name>
</author>
<author>
<name sortKey="Ellert, U" uniqKey="Ellert U">U Ellert</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="O Rien, E" uniqKey="O Rien E">E O’Brien</name>
</author>
<author>
<name sortKey="Petrie, J" uniqKey="Petrie J">J Petrie</name>
</author>
<author>
<name sortKey="Littler, Wa" uniqKey="Littler W">WA Littler</name>
</author>
<author>
<name sortKey="De Swiet, M" uniqKey="De Swiet M">M de Swiet</name>
</author>
<author>
<name sortKey="Padfield, Pl" uniqKey="Padfield P">PL Padfield</name>
</author>
<author>
<name sortKey="Altman, D" uniqKey="Altman D">D Altman</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bianchini, E" uniqKey="Bianchini E">E Bianchini</name>
</author>
<author>
<name sortKey="Brignoli, O" uniqKey="Brignoli O">O Brignoli</name>
</author>
<author>
<name sortKey="Cricelli, C" uniqKey="Cricelli C">C Cricelli</name>
</author>
<author>
<name sortKey="Cricelli, I" uniqKey="Cricelli I">I Cricelli</name>
</author>
<author>
<name sortKey="Giustini, S" uniqKey="Giustini S">S Giustini</name>
</author>
<author>
<name sortKey="Medea, G" uniqKey="Medea G">G Medea</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ferrario, M" uniqKey="Ferrario M">M Ferrario</name>
</author>
<author>
<name sortKey="Chiodini, P" uniqKey="Chiodini P">P Chiodini</name>
</author>
<author>
<name sortKey="Chambless, Le" uniqKey="Chambless L">LE Chambless</name>
</author>
<author>
<name sortKey="Cesana, G" uniqKey="Cesana G">G Cesana</name>
</author>
<author>
<name sortKey="Vanuzzo, D" uniqKey="Vanuzzo D">D Vanuzzo</name>
</author>
<author>
<name sortKey="Panico, S" uniqKey="Panico S">S Panico</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Llisterri, Jl" uniqKey="Llisterri J">JL Llisterri</name>
</author>
<author>
<name sortKey="Rodriguez Roca, Gc" uniqKey="Rodriguez Roca G">GC Rodriguez-Roca</name>
</author>
<author>
<name sortKey="Escobar, C" uniqKey="Escobar C">C Escobar</name>
</author>
<author>
<name sortKey="Alonso Moreno, Fj" uniqKey="Alonso Moreno F">FJ Alonso-Moreno</name>
</author>
<author>
<name sortKey="Prieto, Ma" uniqKey="Prieto M">MA Prieto</name>
</author>
<author>
<name sortKey="Barrios, V" uniqKey="Barrios V">V Barrios</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Catala L Pez, F" uniqKey="Catala L Pez F">F Catalá-López</name>
</author>
<author>
<name sortKey="Ridao, M" uniqKey="Ridao M">M Ridao</name>
</author>
<author>
<name sortKey="Sanfelix Gimeno, G" uniqKey="Sanfelix Gimeno G">G Sanfélix-Gimeno</name>
</author>
<author>
<name sortKey="Peir, S" uniqKey="Peir S">S Peiró</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Joffres, M" uniqKey="Joffres M">M Joffres</name>
</author>
<author>
<name sortKey="Falaschetti, E" uniqKey="Falaschetti E">E Falaschetti</name>
</author>
<author>
<name sortKey="Gillespie, C" uniqKey="Gillespie C">C Gillespie</name>
</author>
<author>
<name sortKey="Robitaille, C" uniqKey="Robitaille C">C Robitaille</name>
</author>
<author>
<name sortKey="Loustalot, F" uniqKey="Loustalot F">F Loustalot</name>
</author>
<author>
<name sortKey="Poulter, N" uniqKey="Poulter N">N Poulter</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Pater, C" uniqKey="Pater C">C Pater</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Laatikainen, T" uniqKey="Laatikainen T">T Laatikainen</name>
</author>
<author>
<name sortKey="Jula, A" uniqKey="Jula A">A Jula</name>
</author>
<author>
<name sortKey="Kastarinen, M" uniqKey="Kastarinen M">M Kastarinen</name>
</author>
<author>
<name sortKey="Salomaa, V" uniqKey="Salomaa V">V Salomaa</name>
</author>
<author>
<name sortKey="Borodulin, K" uniqKey="Borodulin K">K Borodulin</name>
</author>
<author>
<name sortKey="Harald, K" uniqKey="Harald K">K Harald</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Koskinen, S" uniqKey="Koskinen S">S Koskinen</name>
</author>
<author>
<name sortKey="Lundqvist, A" uniqKey="Lundqvist A">A Lundqvist</name>
</author>
<author>
<name sortKey="Ristiluoma, N" uniqKey="Ristiluoma N">N Ristiluoma</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Murray, Cj" uniqKey="Murray C">CJ Murray</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med</journal-id>
<journal-title-group>
<journal-title>BMC Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">1741-7015</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28954635</article-id>
<article-id pub-id-type="pmc">5618725</article-id>
<article-id pub-id-type="publisher-id">934</article-id>
<article-id pub-id-type="doi">10.1186/s12916-017-0934-1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Guideline</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5665-0385</contrib-id>
<name>
<surname>Rehm</surname>
<given-names>Jürgen</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Prieto</surname>
<given-names>Jose Angel Arbesu</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Armstrong</surname>
<given-names>Iain</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aubin</surname>
<given-names>Henri-Jean</given-names>
</name>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bachmann</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bastus</surname>
<given-names>Nuria Bastida</given-names>
</name>
<xref ref-type="aff" rid="Aff14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brotons</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="Aff15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burton</surname>
<given-names>Robyn</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cardoso</surname>
<given-names>Manuel</given-names>
</name>
<xref ref-type="aff" rid="Aff16">16</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colom</surname>
<given-names>Joan</given-names>
</name>
<xref ref-type="aff" rid="Aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duprez</surname>
<given-names>Daniel</given-names>
</name>
<xref ref-type="aff" rid="Aff18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gmel</surname>
<given-names>Gerrit</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff19">19</xref>
<xref ref-type="aff" rid="Aff20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gual</surname>
<given-names>Antoni</given-names>
</name>
<xref ref-type="aff" rid="Aff21">21</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kraus</surname>
<given-names>Ludwig</given-names>
</name>
<xref ref-type="aff" rid="Aff22">22</xref>
<xref ref-type="aff" rid="Aff23">23</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kreutz</surname>
<given-names>Reinhold</given-names>
</name>
<xref ref-type="aff" rid="Aff24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liira</surname>
<given-names>Helena</given-names>
</name>
<xref ref-type="aff" rid="Aff25">25</xref>
<xref ref-type="aff" rid="Aff26">26</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1231-3760</contrib-id>
<name>
<surname>Manthey</surname>
<given-names>Jakob</given-names>
</name>
<address>
<phone>+49 (0) 351 463 36990</phone>
<email>jakob.manthey@tu-dresden.de</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Møller</surname>
<given-names>Lars</given-names>
</name>
<xref ref-type="aff" rid="Aff27">27</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okruhlica</surname>
<given-names>Ľubomír</given-names>
</name>
<xref ref-type="aff" rid="Aff28">28</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roerecke</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scafato</surname>
<given-names>Emanuele</given-names>
</name>
<xref ref-type="aff" rid="Aff29">29</xref>
<xref ref-type="aff" rid="Aff30">30</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schulte</surname>
<given-names>Bernd</given-names>
</name>
<xref ref-type="aff" rid="Aff31">31</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Segura-Garcia</surname>
<given-names>Lidia</given-names>
</name>
<xref ref-type="aff" rid="Aff17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shield</surname>
<given-names>Kevin David</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sierra</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="Aff32">32</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vyshinskiy</surname>
<given-names>Konstantin</given-names>
</name>
<xref ref-type="aff" rid="Aff33">33</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wojnar</surname>
<given-names>Marcin</given-names>
</name>
<xref ref-type="aff" rid="Aff34">34</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zarco</surname>
<given-names>José</given-names>
</name>
<xref ref-type="aff" rid="Aff35">35</xref>
</contrib>
<aff id="Aff1">
<label>1</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Institute for Mental Health Policy Research, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</aff>
<aff id="Aff2">
<label>2</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 8793 5925</institution-id>
<institution-id institution-id-type="GRID">grid.155956.b</institution-id>
<institution>Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,</institution>
</institution-wrap>
Toronto, Canada</aff>
<aff id="Aff3">
<label>3</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Addiction Policy, Dalla Lana School of Public Health,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</aff>
<aff id="Aff4">
<label>4</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Institute of Medical Science, University of Toronto, Faculty of Medicine,</institution>
</institution-wrap>
Medical Sciences Building, Toronto, Canada</aff>
<aff id="Aff5">
<label>5</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id>
<institution-id institution-id-type="GRID">grid.17063.33</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>University of Toronto,</institution>
</institution-wrap>
Toronto, Canada</aff>
<aff id="Aff6">
<label>6</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2111 7257</institution-id>
<institution-id institution-id-type="GRID">grid.4488.0</institution-id>
<institution>Institute of Clinical Psychology and Psychotherapy,</institution>
<institution>Technische Universität Dresden,</institution>
</institution-wrap>
Dresden, Germany</aff>
<aff id="Aff7">
<label>7</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0462 7212</institution-id>
<institution-id institution-id-type="GRID">grid.1006.7</institution-id>
<institution>Substance Use, Policy and Practice, Institute of Health and Society,</institution>
<institution>Newcastle University,</institution>
</institution-wrap>
Newcastle upon Tyne, UK</aff>
<aff id="Aff8">
<label>8</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id>
<institution-id institution-id-type="GRID">grid.5012.6</institution-id>
<institution>Alcohol and Health, Faculty of Health, Medicine and Life Sciences,</institution>
<institution>Maastricht University,</institution>
</institution-wrap>
Maastricht, Netherlands</aff>
<aff id="Aff9">
<label>9</label>
Primary Care Center La Eria, Oviedo, Spain</aff>
<aff id="Aff10">
<label>10</label>
Primary Care Spanish Society SEMERGEN, Madrid, Spain</aff>
<aff id="Aff11">
<label>11</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2196 8713</institution-id>
<institution-id institution-id-type="GRID">grid.9004.d</institution-id>
<institution>Health and Wellbeing Directorate, Public Health England,</institution>
</institution-wrap>
London, UK</aff>
<aff id="Aff12">
<label>12</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0638 6872</institution-id>
<institution-id institution-id-type="GRID">grid.463845.8</institution-id>
<institution>CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud,</institution>
</institution-wrap>
Villejuif, France</aff>
<aff id="Aff13">
<label>13</label>
Copentown Healthcare Consultants, Cape Town, South Africa</aff>
<aff id="Aff14">
<label>14</label>
Primary Health Center, Raval Nord, Barcelona, Spain</aff>
<aff id="Aff15">
<label>15</label>
Sardenya Primary Health Care Center, Biomedical Research Institute Sant Pau, Barcelona, Spain</aff>
<aff id="Aff16">
<label>16</label>
<institution-wrap>
<institution-id institution-id-type="GRID">grid.435474.5</institution-id>
<institution>General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD),</institution>
</institution-wrap>
Lisbon, Portugal</aff>
<aff id="Aff17">
<label>17</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000123317762</institution-id>
<institution-id institution-id-type="GRID">grid.454735.4</institution-id>
<institution>Program on Substance Abuse, Public Health Agency of Catalonia, Department of Health, Government of Catalonia,</institution>
</institution-wrap>
Barcelona, Spain</aff>
<aff id="Aff18">
<label>18</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000419368657</institution-id>
<institution-id institution-id-type="GRID">grid.17635.36</institution-id>
<institution>Cardiovascular Division, School of Medicine,</institution>
<institution>University of Minnesota,</institution>
</institution-wrap>
Minneapolis, USA</aff>
<aff id="Aff19">
<label>19</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 0423 7072</institution-id>
<institution-id institution-id-type="GRID">grid.425461.0</institution-id>
<institution>Implant Systems Group, National ICT Australia,</institution>
</institution-wrap>
Eveleigh, Australia</aff>
<aff id="Aff20">
<label>20</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 4902 0432</institution-id>
<institution-id institution-id-type="GRID">grid.1005.4</institution-id>
<institution>Faculty of Engineering,</institution>
<institution>University of New South Wales,</institution>
</institution-wrap>
Sydney, Australia</aff>
<aff id="Aff21">
<label>21</label>
Addictions Unit, Psychiatry Department, Neurosciences Institute, Hospital Clinic, IDIBAPS, Barcelona, Spain</aff>
<aff id="Aff22">
<label>22</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1017 4547</institution-id>
<institution-id institution-id-type="GRID">grid.417840.e</institution-id>
<institution>IFT Institut für Therapieforschung,</institution>
</institution-wrap>
Munich, Germany</aff>
<aff id="Aff23">
<label>23</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 9377</institution-id>
<institution-id institution-id-type="GRID">grid.10548.38</institution-id>
<institution>Centre for Social Research on Alcohol and Drugs (SoRAD),</institution>
<institution>Stockholm University,</institution>
</institution-wrap>
Stockholm, Sweden</aff>
<aff id="Aff24">
<label>24</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 2218 4662</institution-id>
<institution-id institution-id-type="GRID">grid.6363.0</institution-id>
<institution>Institute of Clinical Pharmacology and Toxicology,</institution>
<institution>Charité - Universitätsmedizin Berlin,</institution>
</institution-wrap>
Berlin, Germany</aff>
<aff id="Aff25">
<label>25</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1936 7910</institution-id>
<institution-id institution-id-type="GRID">grid.1012.2</institution-id>
<institution>General Practice, School of Primary, Aboriginal and Rural Health Care,</institution>
<institution>University of Western Australia,</institution>
</institution-wrap>
Perth, Australia</aff>
<aff id="Aff26">
<label>26</label>
University of Helsinki, Department of General Practice, and Helsinki University Central Hospital, Unit of Primary Health Care, Helsinki, Finland</aff>
<aff id="Aff27">
<label>27</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0001 1939 8248</institution-id>
<institution-id institution-id-type="GRID">grid.420226.0</institution-id>
<institution>Division of Noncommunicable Diseases through the Life Course, WHO Regional Office for Europe,</institution>
</institution-wrap>
Copenhagen, Denmark</aff>
<aff id="Aff28">
<label>28</label>
Centrum pre Liecbu Drogovych Zavislosti, Bratislava, Slovakia</aff>
<aff id="Aff29">
<label>29</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0000 9120 6856</institution-id>
<institution-id institution-id-type="GRID">grid.416651.1</institution-id>
<institution>National Observatory on Alcohol, National Centre on Addiction and Doping, Istituto Superiore di Sanità,</institution>
</institution-wrap>
Rome, Italy</aff>
<aff id="Aff30">
<label>30</label>
Società Italiana di Alcologia (SIA), Italian Society of Alcohology, Bologna, Italy</aff>
<aff id="Aff31">
<label>31</label>
Centre for Interdisciplinary Addiction Research, Hamburg University, Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany</aff>
<aff id="Aff32">
<label>32</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id>
<institution-id institution-id-type="GRID">grid.5841.8</institution-id>
<institution>Hypertension and Vascular Risk Unit, Internal Medicine Department, Hospital Clinic of Barcelona, IDIBAPS,</institution>
<institution>University of Barcelona,</institution>
</institution-wrap>
Barcelona, Spain</aff>
<aff id="Aff33">
<label>33</label>
Research Institute on Addictions, Federal Medical Research Centre for Psychiatry and Narcology n.a. V. Serbsky, Moscow, Russia</aff>
<aff id="Aff34">
<label>34</label>
<institution-wrap>
<institution-id institution-id-type="ISNI">0000000113287408</institution-id>
<institution-id institution-id-type="GRID">grid.13339.3b</institution-id>
<institution>Department of Psychiatry,</institution>
<institution>Medical University of Warsaw,</institution>
</institution-wrap>
Warsaw, Poland</aff>
<aff id="Aff35">
<label>35</label>
Drugs Intervention Group, semFYC, Ibiza Primary Health Care Center, Madrid, Spain</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>15</volume>
<elocation-id>173</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>
), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>
) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12916-017-0934-1) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Hypertension</kwd>
<kwd>Blood pressure</kwd>
<kwd>Alcohol use</kwd>
<kwd>Primary healthcare</kwd>
<kwd>Europe</kwd>
<kwd>Screening</kwd>
<kwd>Management</kwd>
<kwd>Recommendations</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Lundbeck</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Background</title>
<sec id="Sec2">
<title>Alcohol and hypertension as risk factors for non-communicable diseases (NCDs)</title>
<p id="Par11">In May 2013, the World Health Organization (WHO) adopted a Global Action Plan for the Prevention and Control of Non-communicable Diseases for the period 2013–2020. The main target [
<xref ref-type="bibr" rid="CR1">1</xref>
] comprises a 25% reduction in the risk of premature mortality from cardiovascular diseases, cancer, diabetes, or chronic respiratory diseases. To achieve this overall target, a number of individual targets for risk factors have been established, including, but not limited to, at least a 10% reduction in the harmful use of alcohol and a 25% reduction in the prevalence, or limitation of the increase in the prevalence, of raised blood pressure (BP), according to national circumstances. For countries of the European Union, given the consistently high rates of raised BP over the past decades (e.g., [
<xref ref-type="bibr" rid="CR2">2</xref>
]), the 25% reduction of prevalence seems most appropriate [
<xref ref-type="bibr" rid="CR3">3</xref>
].</p>
<p id="Par12">It has been estimated that, if the main targets for risk factors were to be achieved, the overall goal for reduction of premature mortality would be practically reached at the global level [
<xref ref-type="bibr" rid="CR4">4</xref>
], and would be exceeded in the European region [
<xref ref-type="bibr" rid="CR5">5</xref>
]. The measures proposed to reach the NCD goals are centered around the so-called “best buys” of the WHO, interventions that are not only highly cost-effective but also feasible and appropriate to implement within the respective health systems [
<xref ref-type="bibr" rid="CR6">6</xref>
]. Best buys for alcohol comprise taxation increases, restrictions on availability, and a ban on marketing for alcohol use. For hypertension, best buys were more scarce, as only a reduction of salt intake was listed (Appendix 3 of reference [
<xref ref-type="bibr" rid="CR1">1</xref>
]) [
<xref ref-type="bibr" rid="CR6">6</xref>
<xref ref-type="bibr" rid="CR8">8</xref>
]. Herein, we will show, using data from five European countries, that screening and interventions for both hazardous and harmful use of alcohol (including alcohol use disorders (AUDs)) and for hypertension in primary healthcare can also lead to public health-relevant reductions of NCDs in Europe, albeit at higher costs than best buys (see point on economic considerations below), as these are individual-level interventions. In addition, this paper will list recommendations from a consensus conference on what should be performed to achieve these reductions.</p>
</sec>
</sec>
<sec id="Sec3" sec-type="materials|methods">
<title>Methods</title>
<p id="Par13">Herein, the various stages in preparation for and the activities performed at the consensus conference on “Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care” will be outlined. The conference took place in Barcelona on 12th November, 2015, by invitation of the Public Health Agency of Catalonia (see Additional file
<xref rid="MOESM1" ref-type="media">1</xref>
: Appendix 1 for the agenda). Catalonia is one of the few jurisdictions in Europe which has integrated yearly screening for alcohol consumption into its primary healthcare plan. The Public Health Agency prepared the conference [
<xref ref-type="bibr" rid="CR9">9</xref>
].</p>
<sec id="Sec4">
<title>Input into the conference</title>
<p id="Par14">In preparation for the conference, a number of national meetings on its topic were held in Belgium [
<xref ref-type="bibr" rid="CR10">10</xref>
], Finland [
<xref ref-type="bibr" rid="CR11">11</xref>
], Germany [
<xref ref-type="bibr" rid="CR12">12</xref>
], Spain [
<xref ref-type="bibr" rid="CR13">13</xref>
], and the UK [
<xref ref-type="bibr" rid="CR14">14</xref>
], where presentations of systematic reviews and meta-analyses on causality and the relationship between drinking and BP (see below for a summary) and of systematic reviews on the effects of alcohol intervention on BP (see below for a summary) were held. Further, modelling of the potential impact of primary care interventions on alcohol (technical details on the modelling are listed in Appendix 2, following the stipulations of the GATHER statement [
<xref ref-type="bibr" rid="CR15">15</xref>
]) was performed and the results from a survey among primary care physicians on practices concerning alcohol screening and interventions in the management of hypertension [
<xref ref-type="bibr" rid="CR16">16</xref>
] were presented. Finally, draft recommendations, prepared on the basis of the abovementioned national meetings, were put forward.</p>
</sec>
<sec id="Sec5">
<title>Steps towards consensus</title>
<p id="Par15">Each draft recommendation was discussed extensively with a preliminary wording. It was agreed that the preliminary wordings would be circulated again to all participants to achieve a final consensus, together with new evidence as available. The second consultation period took place between 20th September and 20th October, 2016. As part of the revision process for the journal article, new evidence was incorporated and there was a third consultation between February 16th and March 1st, 2017.</p>
</sec>
<sec id="Sec6">
<title>Grading the recommendations</title>
<p id="Par16">We based our recommendations on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, which rates the quality of evidence for a particular outcome across studies and does not rate the quality of individual studies [
<xref ref-type="bibr" rid="CR17">17</xref>
,
<xref ref-type="bibr" rid="CR18">18</xref>
]. For some recommendations, we took the evidence grades from the respective review of UK National Institute for Heath and Care Excellence (NICE), which used the same system to grade the quality of evidence as high, moderate, low, or very low [
<xref ref-type="bibr" rid="CR19">19</xref>
].</p>
</sec>
</sec>
<sec id="Sec7" sec-type="results">
<title>Results and Discussion</title>
<sec id="Sec8">
<title>The evidence for alcohol interventions to reduce BP</title>
<p id="Par17">Several systematic reviews and meta-analyses have shown that alcohol consumption and hypertension are linked in a dose-dependent fashion [
<xref ref-type="bibr" rid="CR20">20</xref>
<xref ref-type="bibr" rid="CR23">23</xref>
], although there may be a threshold level for alcohol consumption below which there are no effects, especially for women [
<xref ref-type="bibr" rid="CR24">24</xref>
,
<xref ref-type="bibr" rid="CR25">25</xref>
] (for indirect evidence see [
<xref ref-type="bibr" rid="CR26">26</xref>
]). As indicated by the potential threshold, the dose-response relationship is not linear over the full range of alcohol consumption, but for both sexes there is a monotonic dose-response relationship for higher levels of consumption [
<xref ref-type="bibr" rid="CR20">20</xref>
,
<xref ref-type="bibr" rid="CR22">22</xref>
,
<xref ref-type="bibr" rid="CR24">24</xref>
], and thus hazardous/harmful drinking and AUDs are closely associated with elevated BP and/or hypertension [
<xref ref-type="bibr" rid="CR23">23</xref>
,
<xref ref-type="bibr" rid="CR27">27</xref>
,
<xref ref-type="bibr" rid="CR28">28</xref>
]. The above described association between hazardous/harmful alcohol consumption and hypertension has been judged as causal [
<xref ref-type="bibr" rid="CR29">29</xref>
<xref ref-type="bibr" rid="CR31">31</xref>
], which means that a logical intervention to reduce BP is to reduce alcohol consumption.</p>
<p id="Par18">Indeed, several studies support the efficacy and effectiveness of interventions to decrease alcohol consumption in reducing BP levels, with a clinically meaningful decline in BP occurring within a few weeks after reductions in alcohol intake among hypertensive patients [
<xref ref-type="bibr" rid="CR30">30</xref>
,
<xref ref-type="bibr" rid="CR32">32</xref>
,
<xref ref-type="bibr" rid="CR33">33</xref>
]. The most comprehensive systematic review and meta-analyses on the effect of alcohol consumption on BP in trials lasting at least 7 days (median duration: 4 weeks) found that, above a baseline drinking level of two drinks per day (drink size was assumed to be 12 g pure alcohol), reduction in alcohol intake was associated with BP reduction [
<xref ref-type="bibr" rid="CR34">34</xref>
]. The higher the alcohol consumption at baseline, the greater the reduction in alcohol consumption and in BP levels. The effect could also be shown for people with hypertension [
<xref ref-type="bibr" rid="CR34">34</xref>
]. The evidence supporting this intervention is of the highest possible grade [
<xref ref-type="bibr" rid="CR35">35</xref>
], as it is based on a systematic review and meta-analyses of randomized controlled trials of interventions to reduce BP in both normotensives and hypertensives, with adequate control groups (for the importance of control groups specifically in the area of interventions for lowering BP see the paper by Patel et al. [
<xref ref-type="bibr" rid="CR36">36</xref>
]).</p>
<p id="Par19">The available evidence has led to standard formulations in European and Canadian guidelines for the management of hypertension in the past decades to address lifestyle factors, including alcohol [
<xref ref-type="bibr" rid="CR37">37</xref>
,
<xref ref-type="bibr" rid="CR38">38</xref>
]. In fact, most guidelines, including those from the NICE, stipulate that all patients undergoing assessment or treatment for hypertension should receive initial and periodic lifestyle advice, which includes ascertaining their alcohol consumption and encouraging a reduced intake if they drink hazardously [
<xref ref-type="bibr" rid="CR39">39</xref>
].</p>
<p id="Par20">The situation in the US is slightly different. Although American Society of Hypertension Community Guidelines briefly mention the contribution of alcohol to raised BP [
<xref ref-type="bibr" rid="CR40">40</xref>
], the association between alcohol consumption and raised BP is not even mentioned in the main national hypertension guidelines [
<xref ref-type="bibr" rid="CR41">41</xref>
] or in the American College of Cardiology/American Heart Association Guidelines regarding lifestyle management to reduce cardiovascular risk [
<xref ref-type="bibr" rid="CR42">42</xref>
].</p>
</sec>
<sec id="Sec9">
<title>Interventions to reduce alcohol consumption</title>
<p id="Par21">In the primary care settings, there is significant overlap of hazardous drinking/AUDs (for background see [
<xref ref-type="bibr" rid="CR43">43</xref>
]) and hypertension. European evidence suggests that 20.6% of hypertensive men aged 40–65 years have an AUD and 16.7% have alcohol dependence. For hypertensive women aged 40–65 years, it is estimated that 7.2% have an AUD and 5.8% have alcohol dependence [
<xref ref-type="bibr" rid="CR12">12</xref>
]. Adding these people to those who do not qualify for an AUD diagnosis but drink above 60 g or 40 g of pure alcohol per day (for men and women, respectively), resulted in 30.9% or 20.0% of men and women aged 40–65 years, respectively, qualifying for alcohol interventions with hypertension. Compared to those without any AUD, patients with an AUD are estimated to have a 1.5- to 5-fold increased risk of hypertension, with the highest risks for hypertension involving higher levels of alcohol consumption [
<xref ref-type="bibr" rid="CR44">44</xref>
<xref ref-type="bibr" rid="CR46">46</xref>
]. In the above-cited study of more than 13,000 patients in primary healthcare [
<xref ref-type="bibr" rid="CR28">28</xref>
,
<xref ref-type="bibr" rid="CR47">47</xref>
], the age-adjusted odds ratio (OR) for hypertension in the age group 40–64 years was 1.59 among those diagnosed with AUD by the treating general practitioner (95% CI 1.35–1.88,
<italic>P</italic>
 < 0.001; own calculations – see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2) [
<xref ref-type="bibr" rid="CR47">47</xref>
<xref ref-type="bibr" rid="CR49">49</xref>
].</p>
<p id="Par22">Looking at the odds from hypertension in the cited study, the age-adjusted OR for an AUD was, of course, similar (OR 1.60, 95% CI 1.35–1.88,
<italic>P</italic>
 < 0.001) because of the symmetry property of OR, and the odds of qualifying for an intervention among people with hypertension was 1.35 (95% CI 1.12–1.58,
<italic>P</italic>
 < 0.001; own calculations; for a description of the study see [
<xref ref-type="bibr" rid="CR47">47</xref>
<xref ref-type="bibr" rid="CR49">49</xref>
]).</p>
<p id="Par23">Since a reduction in alcohol consumption leads to a decline in BP levels [
<xref ref-type="bibr" rid="CR32">32</xref>
,
<xref ref-type="bibr" rid="CR34">34</xref>
], the question becomes whether effective interventions to reduce alcohol consumption are available in primary healthcare. There is ample evidence, based on randomized controlled trials in many countries, that screening and brief advice are effective in reducing alcohol consumption in hazardous and harmful drinkers [
<xref ref-type="bibr" rid="CR50">50</xref>
], and that effective psychotherapies and pharmacotherapy plus psychosocial interventions are effective in reducing consumption levels in dependent drinkers [
<xref ref-type="bibr" rid="CR51">51</xref>
<xref ref-type="bibr" rid="CR55">55</xref>
]. Despite this evidence, and its inclusion in some guidelines [
<xref ref-type="bibr" rid="CR37">37</xref>
,
<xref ref-type="bibr" rid="CR39">39</xref>
], interventions to reduce alcohol consumption do not play a major role in the management of hypertension at the primary healthcare level in many European countries [
<xref ref-type="bibr" rid="CR16">16</xref>
,
<xref ref-type="bibr" rid="CR56">56</xref>
]. One example that illustrates the paucity of activity in primary healthcare is the recent five-country Optimizing Delivery of Health Care Interventions study that recruited 120 primary healthcare units from Catalonia, England, Netherlands, Poland, and Sweden [
<xref ref-type="bibr" rid="CR57">57</xref>
]. During the 4-week baseline measurement period, in only 1202 out of 179,954 adult consultations (0.67%) were patients screened for and advised about their hazardous drinking.</p>
<p id="Par24">Studies have identified a number of potential barriers to the adoption of screening and brief advice in primary healthcare, including the lack of resources, training and support from management, as well as workload [
<xref ref-type="bibr" rid="CR58">58</xref>
,
<xref ref-type="bibr" rid="CR59">59</xref>
]. Given this situation, experts in several countries have started to take steps towards better integration of alcohol interventions in primary healthcare [
<xref ref-type="bibr" rid="CR10">10</xref>
<xref ref-type="bibr" rid="CR14">14</xref>
]. Despite obvious differences between healthcare systems, there are clear commonalities in the recommendations made by the different sets of national experts. These recommendations focus on providing incentives for screening and treatment, better education for primary healthcare providers regarding the link between alcohol and hypertension, and the inclusion of simple alcohol tools in electronic patient records, such that the management of alcohol use becomes standard practice for all patients with hypertension.</p>
</sec>
<sec id="Sec10">
<title>The potential in Europe – examples from five countries</title>
<p id="Par25">While control and management of hypertension is a key element of any European guideline for primary healthcare, most general population surveys show that a large minority of women and the majority of men with hypertension aged 40 to 64 either do not know about their health condition or are not adequately controlled (i.e., they show BP values ≥ 140/90 mm Hg; see Table 
<xref rid="Tab1" ref-type="table">1</xref>
for details).
<table-wrap id="Tab1">
<label>Table 1</label>
<caption>
<p>Proportion with hypertension with or without control in large population surveys among 40–64 year olds</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2"></th>
<th colspan="2">Proportion of people with hypertension
<sup>a</sup>
</th>
<th colspan="2">Proportion recognized or in treatment (with or without adequate control)
<sup>b</sup>
</th>
<th rowspan="2">Fieldwork of main study</th>
</tr>
<tr>
<th>Women</th>
<th>Men</th>
<th>Women</th>
<th>Men</th>
</tr>
</thead>
<tbody>
<tr>
<td>France</td>
<td>30.4%</td>
<td>46.2%</td>
<td>64.0%</td>
<td>36.1%</td>
<td>2006–2007</td>
</tr>
<tr>
<td>Germany</td>
<td>29.6%</td>
<td>36.5%</td>
<td>56.0%</td>
<td>40.1%</td>
<td>2008–2011</td>
</tr>
<tr>
<td>Italy</td>
<td>33.2%</td>
<td>42.1%</td>
<td>52.0%</td>
<td>40.4%</td>
<td>2008–2012</td>
</tr>
<tr>
<td>Spain</td>
<td>30.0%</td>
<td>42.0%</td>
<td>62.0%</td>
<td>48.1%</td>
<td>2008–2010</td>
</tr>
<tr>
<td>UK</td>
<td>22.6%</td>
<td>27.2%</td>
<td>31.2%</td>
<td>23.9%</td>
<td>2006</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>For definitions and sources, see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2</p>
<p>
<sup>a</sup>
Hypertension was defined by a blood pressure ≥ 140/90 mm Hg or by being on hypertensive medication</p>
<p>
<sup>b</sup>
Neither recognition nor initiation of hypertension treatment implies that the patient is adequately controlled (i.e., below 140/90 mm Hg). The number of people without adequately controlled hypertension among those recognized/treated varies from country to country and usually exceeds the number of people with adequate control</p>
</table-wrap-foot>
</table-wrap>
</p>
<p id="Par26">The following models the joint effects of two interventions (see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2). First, it is assumed that 50% of the people aged 40–64 years with uncontrolled hypertension (i.e., BP ≥ 140/90 mm Hg [
<xref ref-type="bibr" rid="CR37">37</xref>
,
<xref ref-type="bibr" rid="CR60">60</xref>
,
<xref ref-type="bibr" rid="CR61">61</xref>
]) receive an intervention (in part but not limited to pharmacotherapy [
<xref ref-type="bibr" rid="CR37">37</xref>
]), which lowers their BP level to that of people with controlled hypertension. Secondly, it is assumed that, among those with uncontrolled hypertension who are receiving hypertension interventions, 50% of those eligible will also receive either brief advice or a brief intervention for hazardous or harmful alcohol use, or treatment for alcohol dependence. The results are summarized in Table 
<xref rid="Tab2" ref-type="table">2</xref>
.
<table-wrap id="Tab2">
<label>Table 2</label>
<caption>
<p>Blood pressure indicators among people with hypertension before and after the interventions among people with hypertension, 40–64 years old</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2"></th>
<th rowspan="2">Sex</th>
<th colspan="2">Mean systolic BP
<sup>a</sup>
</th>
<th rowspan="2">Δ
<sup>b</sup>
</th>
<th colspan="2">% ≥ 140/90 mm Hg
<sup>a</sup>
</th>
<th rowspan="2">Δ
<sup>c</sup>
</th>
<th rowspan="2">General population
<sup>d</sup>
</th>
</tr>
<tr>
<th>before</th>
<th>after</th>
<th>before</th>
<th>after</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="2">France</td>
<td>W</td>
<td char="." align="char">140.7</td>
<td char="." align="char">138.1</td>
<td char="." align="char">2.5</td>
<td>48%</td>
<td>41%</td>
<td>7%</td>
<td>2.0%</td>
</tr>
<tr>
<td>M</td>
<td char="." align="char">146.3</td>
<td char="." align="char">141.0</td>
<td char="." align="char">5.3</td>
<td>59%</td>
<td>48%</td>
<td>11%</td>
<td>5.3%</td>
</tr>
<tr>
<td rowspan="2">Germany</td>
<td>W</td>
<td char="." align="char">141.5</td>
<td char="." align="char">138.5</td>
<td char="." align="char">3.0</td>
<td>49%</td>
<td>42%</td>
<td>7%</td>
<td>2.0%</td>
</tr>
<tr>
<td>M</td>
<td char="." align="char">143.9</td>
<td char="." align="char">139.8</td>
<td char="." align="char">4.2</td>
<td>55%</td>
<td>45%</td>
<td>9%</td>
<td>3.4%</td>
</tr>
<tr>
<td rowspan="2">Italy</td>
<td>W</td>
<td char="." align="char">144.7</td>
<td char="." align="char">142.1</td>
<td char="." align="char">2.6</td>
<td>56%</td>
<td>51%</td>
<td>6%</td>
<td>1.8%</td>
</tr>
<tr>
<td>M</td>
<td char="." align="char">144.2</td>
<td char="." align="char">139.7</td>
<td char="." align="char">4.4</td>
<td>55%</td>
<td>45%</td>
<td>10%</td>
<td>4.0%</td>
</tr>
<tr>
<td rowspan="2">Spain</td>
<td>W</td>
<td char="." align="char">146.0</td>
<td char="." align="char">144.6</td>
<td char="." align="char">1.4</td>
<td>60%</td>
<td>57%</td>
<td>3%</td>
<td>1.0%</td>
</tr>
<tr>
<td>M</td>
<td char="." align="char">146.8</td>
<td char="." align="char">144.9</td>
<td char="." align="char">1.9</td>
<td>62%</td>
<td>57%</td>
<td>4%</td>
<td>1.8%</td>
</tr>
<tr>
<td rowspan="2">UK</td>
<td>W</td>
<td char="." align="char">141.5</td>
<td char="." align="char">139.5</td>
<td char="." align="char">2.0</td>
<td>50%</td>
<td>45%</td>
<td>5%</td>
<td>1.1%</td>
</tr>
<tr>
<td>M</td>
<td char="." align="char">145.4</td>
<td char="." align="char">142.8</td>
<td char="." align="char">2.5</td>
<td>58%</td>
<td>52%</td>
<td>5%</td>
<td>1.5%</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>For definitions and sources, see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2 [
<xref ref-type="bibr" rid="CR109">109</xref>
]</p>
<p>
<sup>a</sup>
Blood pressure (BP) in mm Hg among people with hypertension, defined by a BP ≥ 140/90 mm Hg or by being on hypertensive medication</p>
<p>
<sup>b</sup>
Difference between before and after interventions in mm Hg</p>
<p>
<sup>c</sup>
% difference between before and after interventions</p>
<p>
<sup>d</sup>
% increase of people below the threshold of 140/90 mm Hg in the general population</p>
</table-wrap-foot>
</table-wrap>
</p>
<p id="Par27">In each of the countries, the proposed intervention would have a sizeable effect on improving BP levels among 40- to 65-year-old hypertensives and would markedly increase the proportion of people below the threshold 140/90 mm Hg in the general population (for men, between 1.5% and 5.3%; for women, between 1.0% and 2.0%). Both effects are more pronounced in men, which is not surprising, as men have worse control of BP in all countries and, relatedly, they have worse alcohol consumption habits [
<xref ref-type="bibr" rid="CR1">1</xref>
] (Table 
<xref rid="Tab2" ref-type="table">2</xref>
).</p>
<p id="Par28">The next set of calculations measures the impact of the proposed interventions on mortality and burden of disease as measured in disability-adjusted live years (DALYs) in the same age group within 1 year, using the methodology of comparative risk assessment [
<xref ref-type="bibr" rid="CR62">62</xref>
,
<xref ref-type="bibr" rid="CR63">63</xref>
] (see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2). This limitation for 1 year is consistent with knowledge that brief intervention effects will show some attrition over time [
<xref ref-type="bibr" rid="CR64">64</xref>
].</p>
<p id="Par29">The potential effect of the interventions on reducing mortality would be sizeable. In each of the five countries examined, the reductions of BP and the effects of reduced alcohol would lead to hundreds of deaths avoided within 1 year (Table 
<xref rid="Tab3" ref-type="table">3</xref>
); for instance, in Germany alone, a reduction of 1536 cardiovascular disease deaths, 138 gastrointestinal deaths, and 20 injury deaths. In terms of burden of disease, for Germany, about 86,000 years of life lost due to cardiovascular premature mortality or due to disability in this age group could be avoided, plus another 5500 due to gastrointestinal disease and 3000 due to injury.
<table-wrap id="Tab3">
<label>Table 3</label>
<caption>
<p>Lives saved and disability-adjusted life years avoided in major disease categories within 12 months attributable to the interventions among people with hypertension, 40–64 years old</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2">Deaths</th>
<th></th>
<th colspan="3">Cardiovascular disease</th>
<th colspan="2">Gastrointestinal disease</th>
<th></th>
</tr>
<tr>
<th></th>
<th>Total</th>
<th>Attributable to IHD</th>
<th>Attributable to stroke</th>
<th>Total</th>
<th>Attributable to liver cirrhosis</th>
<th>Injury</th>
</tr>
</thead>
<tbody>
<tr>
<td>France</td>
<td>W</td>
<td>111</td>
<td>25</td>
<td>47</td>
<td>12</td>
<td>11</td>
<td>3</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>1041</td>
<td>443</td>
<td>276</td>
<td>109</td>
<td>88</td>
<td>30</td>
</tr>
<tr>
<td>Germany</td>
<td>W</td>
<td>275</td>
<td>83</td>
<td>98</td>
<td>25</td>
<td>22</td>
<td>2</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>1261</td>
<td>633</td>
<td>246</td>
<td>113</td>
<td>100</td>
<td>18</td>
</tr>
<tr>
<td>Italy</td>
<td>W</td>
<td>158</td>
<td>42</td>
<td>57</td>
<td>10</td>
<td>9</td>
<td>1</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>805</td>
<td>389</td>
<td>180</td>
<td>98</td>
<td>82</td>
<td>15</td>
</tr>
<tr>
<td>Spain</td>
<td>W</td>
<td>50</td>
<td>16</td>
<td>22</td>
<td>4</td>
<td>3</td>
<td>1</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>301</td>
<td>164</td>
<td>76</td>
<td>48</td>
<td>38</td>
<td>8</td>
</tr>
<tr>
<td>UK</td>
<td>W</td>
<td>77</td>
<td>27</td>
<td>29</td>
<td>25</td>
<td>24</td>
<td>2</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>378</td>
<td>220</td>
<td>78</td>
<td>84</td>
<td>75</td>
<td>11</td>
</tr>
<tr>
<td>DALYs</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>France</td>
<td>W</td>
<td>10,590</td>
<td>2850</td>
<td>5189</td>
<td>456</td>
<td>417</td>
<td>418</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>56,844</td>
<td>23,237</td>
<td>19,335</td>
<td>4235</td>
<td>3710</td>
<td>2914</td>
</tr>
<tr>
<td>Germany</td>
<td>W</td>
<td>21,179</td>
<td>7042</td>
<td>8703</td>
<td>1007</td>
<td>943</td>
<td>599</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>64,840</td>
<td>31,245</td>
<td>16,983</td>
<td>4491</td>
<td>4022</td>
<td>2379</td>
</tr>
<tr>
<td>Italy</td>
<td>W</td>
<td>15,543</td>
<td>4948</td>
<td>5872</td>
<td>489</td>
<td>452</td>
<td>536</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>47,273</td>
<td>21,992</td>
<td>13,020</td>
<td>4305</td>
<td>3777</td>
<td>2491</td>
</tr>
<tr>
<td>Spain</td>
<td>W</td>
<td>4764</td>
<td>1483</td>
<td>2100</td>
<td>181</td>
<td>159</td>
<td>233</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>16,419</td>
<td>8086</td>
<td>5007</td>
<td>1934</td>
<td>1660</td>
<td>1198</td>
</tr>
<tr>
<td>UK</td>
<td>W</td>
<td>4860</td>
<td>1648</td>
<td>2117</td>
<td>1012</td>
<td>936</td>
<td>495</td>
</tr>
<tr>
<td></td>
<td>M</td>
<td>18,354</td>
<td>9581</td>
<td>5348</td>
<td>3394</td>
<td>3033</td>
<td>1632</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>For definitions and sources, see Additional file
<xref rid="MOESM2" ref-type="media">2</xref>
: Appendix 2</p>
<p>
<italic>IHD</italic>
ischemic heart disease,
<italic>DALYs</italic>
disability-adjusted life years</p>
</table-wrap-foot>
</table-wrap>
</p>
<p id="Par30">This does not even include the effect of reduced alcohol use on other disease categories such as AUDs or cancer. For the latter disease category, the effects would only be seen after decades due to the long time lag [
<xref ref-type="bibr" rid="CR65">65</xref>
]. For the other disease categories, lag times are short [
<xref ref-type="bibr" rid="CR66">66</xref>
], and the vast majority of deaths will be covered, including liver cirrhosis deaths, where interventions have shown immediate effects [
<xref ref-type="bibr" rid="CR67">67</xref>
].</p>
</sec>
</sec>
<sec id="Sec11">
<title>Recommendations</title>
<p id="Par31">
<list list-type="order">
<list-item>
<p id="Par32">
<italic>Increase screening for hypertension in primary healthcare</italic>
.</p>
<p id="Par33">Evidence grade: High. Despite control of hypertension being an integral part of primary healthcare in most European countries, a measurable proportion of the patients with undetected hypertension is evident in all countries, usually among the younger age groups (see Table 
<xref rid="Tab1" ref-type="table">1</xref>
for details for the five countries modelled). As a result, many countries make specific recommendations for the screening of hypertension via regular measurement of BP (for example, for the UK see the Quality and Outcomes Framework indicator set by the National Health Service; for underlying evidence see reviews [
<xref ref-type="bibr" rid="CR68">68</xref>
<xref ref-type="bibr" rid="CR70">70</xref>
] or large trials [
<xref ref-type="bibr" rid="CR71">71</xref>
]). The evidence for these screening efforts was graded as the highest possible quality, and current explorations are mainly concerned with best techniques for assessing BP [
<xref ref-type="bibr" rid="CR68">68</xref>
,
<xref ref-type="bibr" rid="CR72">72</xref>
].</p>
</list-item>
<list-item>
<p id="Par34">
<italic>Increase screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension from physicians, nurses, and other healthcare professionals in primary healthcare</italic>
.</p>
<p id="Par35">Evidence grade: High. Even though this recommendation has not been implemented into clinical practice in most countries, the evidence grade from controlled clinical studies has been evaluated as consistently high (see [
<xref ref-type="bibr" rid="CR50">50</xref>
,
<xref ref-type="bibr" rid="CR64">64</xref>
,
<xref ref-type="bibr" rid="CR73">73</xref>
] for effectiveness of brief advice for reducing drinking; see [
<xref ref-type="bibr" rid="CR32">32</xref>
,
<xref ref-type="bibr" rid="CR34">34</xref>
] for meta-analyses of alcohol interventions on BP, including on BP levels of people with hypertension).</p>
</list-item>
<list-item>
<p id="Par36">
<italic>Treatment for less severe alcohol use disorders in people with incident hypertension should be conducted in primary healthcare, including but not limited to pharmacologically assisted treatment</italic>
.</p>
<p id="Par37">Evidence grade: Moderate. While there are some recommendations for treatment of less severe AUDs in primary healthcare [
<xref ref-type="bibr" rid="CR74">74</xref>
<xref ref-type="bibr" rid="CR76">76</xref>
] and randomized controlled trials on specific elements of this strategy (e.g., effectiveness of medication-assisted treatment [
<xref ref-type="bibr" rid="CR77">77</xref>
,
<xref ref-type="bibr" rid="CR78">78</xref>
]), the strategy has not been systematically tested in randomized controlled clinical trials. Additionally, to date, it has not been tested specifically for people with hypertension in primary healthcare, even though there is evidence from randomized controlled trials that treatment for AUDs can lower BP [
<xref ref-type="bibr" rid="CR33">33</xref>
,
<xref ref-type="bibr" rid="CR79">79</xref>
<xref ref-type="bibr" rid="CR81">81</xref>
]. This is to be expected, as AUDs are strongly associated with hazardous or harmful drinking levels [
<xref ref-type="bibr" rid="CR43">43</xref>
,
<xref ref-type="bibr" rid="CR82">82</xref>
], and abstinence or reduction of drinking is the main outcome variable in most of these trials [
<xref ref-type="bibr" rid="CR83">83</xref>
].</p>
</list-item>
<list-item>
<p id="Par38">
<italic>Screen for alcohol use in hypertension that is not well controlled</italic>
.</p>
<p id="Par39">Evidence grade: Moderate. Current guidelines for the management for treatment-resistant hypertension, comprising approximately 8–12% of patients with uncontrolled BP [
<xref ref-type="bibr" rid="CR84">84</xref>
], emphasize screening of alcohol use and reduction of hazardous or harmful drinking levels [
<xref ref-type="bibr" rid="CR85">85</xref>
,
<xref ref-type="bibr" rid="CR86">86</xref>
]. However, there are no randomized clinical trials underlying this recommendation; it is supported mainly by biological plausibility and, in a recent assessment [
<xref ref-type="bibr" rid="CR86">86</xref>
], the relevant committee of the French Society for Hypertension gave it a moderate evidence grade.</p>
</list-item>
</list>
</p>
</sec>
<sec id="Sec12">
<title>Economic considerations</title>
<p id="Par40">Thus far, we have only considered estimated effects of implementing both interventions, indicating public health-relevant effects on BP and premature mortality (as all calculations were restricted to people aged 40–65 years). Others have shown effects on wider outcomes as well (see [
<xref ref-type="bibr" rid="CR34">34</xref>
] for effects on BP-attributable hospitalizations; Organisation for Economic Co-operation and Development [
<xref ref-type="bibr" rid="CR87">87</xref>
] for estimating and comparing effects on alcohol interventions on disease burden). For any change in healthcare systems, information about costs are also necessary, as effective interventions may not be taken up if they are not cost-effective. A recent systematic review showed that brief interventions in primary healthcare have also been shown to be cost-effective [
<xref ref-type="bibr" rid="CR88">88</xref>
]. In addition, Angus et al. [
<xref ref-type="bibr" rid="CR89">89</xref>
] estimated, by modelling potential effects of implementing screening and brief interventions for hazardous or harmful drinking, that these programs were likely to be cost-effective in 24 out of 28 European Union countries and cost-saving in 50% of these. They concluded that implementing national alcohol intervention programs in primary healthcare would be a cost-effective means to reduce health burden. However, it should be noted that the work of Angus et al. [
<xref ref-type="bibr" rid="CR89">89</xref>
] was not limited to the consequences mediated by BP, but included all health consequences.</p>
<p id="Par41">Given these numbers, and bearing in mind that there is only one best buy for hypertension (Appendix 3 of [
<xref ref-type="bibr" rid="CR1">1</xref>
]) and, further, that the three best buys for alcohol have been rarely considered by decision-makers given the strong impact of economic operators and the fear that taxation increases and availability restrictions would prove unpopular with many voters [
<xref ref-type="bibr" rid="CR90">90</xref>
], implementing alcohol interventions for people with newly detected hypertension seems an attractive and feasible option to improve public health at relatively low, or for some jurisdictions, no overall costs.</p>
</sec>
<sec id="Sec13" sec-type="conclusion">
<title>Potential for implementation and conclusions</title>
<p id="Par42">All of the four recommendations have been chosen as measurable, achievable, and realistic for implementation in primary healthcare. Obviously, as with all recommendations, implementations should be carefully evaluated. While we have laid out the economic arguments for implementing the recommendations, these are currently based on assumptions and different modelling approaches. More controlled approaches with randomization should be used to study the effects of the recommendations. Moreover, evaluations, including but not limited to economic evaluations [
<xref ref-type="bibr" rid="CR91">91</xref>
], are necessary to create sustainable policies, which could be defended in times of scarce resources.</p>
<p id="Par43">During implementation, priority should be given to the integration of routine screening for alcohol (recommendation 2) and interventions for hazardous and harmful drinking (recommendation 2) and AUDs (recommendation 3) into the management of hypertension. Improved training and better remuneration systems, specifically adapted to the different healthcare systems, are crucial [
<xref ref-type="bibr" rid="CR57">57</xref>
]. Some of the current steps in this direction are promising, and we hope that the reasoning and recommendations of this consensus paper can provide further important momentum to move European healthcare systems in this direction.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec14">
<title>Additional file</title>
<p id="Par77">
<media position="anchor" xlink:href="12916_2017_934_MOESM1_ESM.pdf" id="MOESM1">
<label>Additional file 1:</label>
<caption>
<p>Appendix 1. Workshop agenda. (PDF 148 kb)</p>
</caption>
</media>
<media position="anchor" xlink:href="12916_2017_934_MOESM2_ESM.pdf" id="MOESM2">
<label>Additional file 2:</label>
<caption>
<p>Appendix 2. Methodology [
<xref ref-type="bibr" rid="CR92">92</xref>
<xref ref-type="bibr" rid="CR108">108</xref>
]. (PDF 824 kb)</p>
</caption>
</media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AUDs</term>
<def>
<p id="Par5">Alcohol use disorders</p>
</def>
</def-item>
<def-item>
<term>BP</term>
<def>
<p id="Par6">Blood pressure</p>
</def>
</def-item>
<def-item>
<term>DALYs</term>
<def>
<p id="Par7">Disability-adjusted life years</p>
</def>
</def-item>
<def-item>
<term>NCDs</term>
<def>
<p id="Par8">Non-communicable Diseases</p>
</def>
</def-item>
<def-item>
<term>NICE</term>
<def>
<p id="Par9">National Institute for Heath and Care Excellence</p>
</def>
</def-item>
<def-item>
<term>WHO</term>
<def>
<p id="Par10">World Health Organization</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (doi:10.1186/s12916-017-0934-1) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>It should be noted that the views reported in this paper do not necessarily represent the views of the authors’ employing organizations.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par44">The workshop entitled “Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care”, held on November 12, 2015, in Barcelona, Spain, was financially supported by Lundbeck (in providing travel allowances for some participants). An agenda of the workshop can be found in Additional file
<xref rid="MOESM1" ref-type="media">1</xref>
: Appendix 1.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par45">Data sources used for modelling are referenced. No primary data were used.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>All authors, except for DD, GG, JM, JAAP, and KDS, participated at the “Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care” conference in Barcelona. The discussions during this conference were condensed and compiled by JR, which resulted in the first draft of the manuscript. DD, GG, JM, JAAP, and KDS contributed critical content to this manuscript. All authors contributed to and approved of the final version.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par46">Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par47">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par48">JR reports grants, personal fees and serving as board member (Nalmefene up to 2014) for Lundbeck. PA reports no competing interests. JAAP reports grants and personal fees from Lundbeck. IA reports no competing interests. H-JA reports serving as board member for Pfizer, D&A Pharma, Ethypharm, and Lundbeck, and receiving sponsorships, speaker honoraria and consultancy fees from Bioprojet, D&A Pharma, Ethypharm, Lundbeck, Merck-Serono, Novartis, and Pfizer. MB reports consulting fees received from Lundbeck (through consulting business Copentown) for organisational and process support in connection with the project. Copentown, which is owned by MB, also has other pharmaceutical/healthcare clients. NBB reports funding from Lundbeck for a research project on alcohol. CB reports consulting fees from Lundbeck. RB reports no competing interests. MC reports no competing interests. JC reports sponsorship from Lundbeck to attend scientific meetings. DD received consultant fee form Lundbeck. GG reports no competing interests. AG reports grants and personal fees from Lundbeck and D&A Pharma, grants from TEVA, and personal fees from Abbivie. LK reports funding from Lundbeck for a research project on alcohol. RK received honoraria for consultancy, lectures and support for research from Bayer Pharma, Berlin-Chemie Menarini, Bristol-Myers Squibb, Daiichi Sankyo, Lundbeck, and Servier. HL reports consultation fee from Lundbeck. JM reports personal fees from Lundbeck. LM reports no competing interests. LO reports no competing interests. MR reports no competing interests. ES reports sponsorship to attend scientific meetings from Lundbeck. BS reports no competing interests. LS-G reports sponsorship from Lundbeck to attend one scientific meeting. KDS reports no competing interests. CS reports sponsorship to attend scientific meetings from Lundbeck. KV reports no competing interests. MW reports personal fees from AOP Orphan, Berlin Chemie, Janssen, Lundbeck, D&A Pharma, Reckitt Benckiser. JZ reports personal fees from Lundbeck, and consultancy fees and salaries from Menarini, Lilly and Gilead.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>Global Action Plan for the Prevention and Control of NCDs 2013-2020</source>
<year>2013</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>WHO</publisher-name>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf-Maier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Banegas</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Giampaoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hense</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Joffres</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States</article-title>
<source>JAMA</source>
<year>2003</year>
<volume>289</volume>
<fpage>2363</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1001/jama.289.18.2363</pub-id>
<pub-id pub-id-type="pmid">12746359</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>A global brief on hypertension</source>
<year>2013</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>WHO</publisher-name>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kontis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mathers</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Shield</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Bonita</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of six risk factors to achieving the “25 × 25” NCD mortality reduction target</article-title>
<source>Lancet</source>
<year>2014</year>
<volume>384</volume>
<fpage>427</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(14)60616-4</pub-id>
<pub-id pub-id-type="pmid">24797573</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kontis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mathers</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Bonita</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shield</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study</article-title>
<source>Lancet Glob Health</source>
<year>2015</year>
<volume>3</volume>
<fpage>e746</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/S2214-109X(15)00179-5</pub-id>
<pub-id pub-id-type="pmid">26497599</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Economic Forum & World Health Organization</collab>
</person-group>
<source>From burden to “best buys”: Reducing the economic impact of non-communicable diseases in low- and middle-income countries</source>
<year>2011</year>
<publisher-loc>Davos</publisher-loc>
<publisher-name>World Economic Forum</publisher-name>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chisholm</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Ommeren</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis</article-title>
<source>J Stud Alcohol</source>
<year>2004</year>
<volume>65</volume>
<fpage>782</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.15288/jsa.2004.65.782</pub-id>
<pub-id pub-id-type="pmid">15700517</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>Discussion Paper: Prevention and Control of NCDs: Priorities for Investment</source>
<year>2011</year>
<publisher-loc>Moscow</publisher-loc>
<publisher-name>First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control</publisher-name>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Department of Health</collab>
</person-group>
<source>Health Plan of Catalonia 2016-2020</source>
<year>2016</year>
<publisher-loc>Barcelona</publisher-loc>
<publisher-name>Government of Catalonia</publisher-name>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collart</surname>
<given-names>F</given-names>
</name>
<name>
<surname>de Timary</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dom</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dor</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Duprez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lengelé</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol-induced hypertension: an important healthcare target in Belgium</article-title>
<source>Acta Clin Belg</source>
<year>2015</year>
<volume>70</volume>
<fpage>389</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1179/2295333715Y.0000000039</pub-id>
<pub-id pub-id-type="pmid">26135944</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aalto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jula</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Keinänen-Kiukaanniemi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liira</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Räsänen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alkoholinkäytön suitsiminen vähentää kohonneen verenpaineen haittoja. Alkoholiseulonta, mini-interventiot ja riippuvuuden hoito voisivat merkittävästi vähentää kohonnutta verenpainetta sairastavien määrää. [Tackling alcohol consumption reduces high blood pressure damage. Alcohol Screening, brief-interventions and addiction treatment could significantly reduce elevated blood pressure in patients]</article-title>
<source>Suomen Lääkärilehti</source>
<year>2017</year>
<volume>35</volume>
<fpage>2177</fpage>
<lpage>2179A</lpage>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gmel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kiefer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kreutz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kugler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Müller-Walther</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Verbessertes Hypertonie-Management durch Alkohol-Screening und Folgeinterventionen in der Hausarztpraxis</article-title>
<source>Deu Med Wochenschr</source>
<year>2014</year>
<volume>139</volume>
<fpage>2457</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1055/s-0034-1387417</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zarco</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Colom</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Cribado precoz e intervención breve en el consumo perjudicial de alcohol para mejorar el tratamiento de la hipertensión arterial en atención primaria</article-title>
<source>Med Clin Barcelona</source>
<year>2016</year>
<volume>146</volume>
<fpage>81</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.medcli.2015.07.014</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<mixed-citation publication-type="other">Ballard J, Brown A, D’Agnone O, Grimm C, Gunson B, Harris L et al. Under Pressure: Tackling two of the most most common preventable health harms in the UK; high blood pressure and excessive alcohol consumption. Lundbeck. 2015.
<ext-link ext-link-type="uri" xlink:href="https://www.alcohollearningcentre.org.uk/_assets/Treat%2015%20Under%20Pressure.pdf">https://www.alcohollearningcentre.org.uk/_assets/Treat%2015%20Under%20Pressure.pdf</ext-link>
. Accessed 7 Oct 2016.</mixed-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Alkema</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Boerma</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Ezzati</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Guidelines for accurate and transparent health estimates reporting: the GATHER statement</article-title>
<source>Lancet</source>
<year>2016</year>
<volume>388</volume>
<fpage>e19</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(16)30388-9</pub-id>
<pub-id pub-id-type="pmid">27371184</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Angel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Prieto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duhot</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of alcohol in the management of hypertension in patients in European primary health care practices – a survey in the largest European Union countries</article-title>
<source>BMC Fam Prac</source>
<year>2016</year>
<volume>17</volume>
<fpage>130</fpage>
<pub-id pub-id-type="doi">10.1186/s12875-016-0529-5</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>The GRADE Working Group</collab>
</person-group>
<source>What is GRADE?</source>
<year>2016</year>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>U.S. Department of Health and Human Services</collab>
</person-group>
<source>Lifestyle Interventions to Reduce Cardiovascular Risk</source>
<year>2013</year>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>National Institute for Health and Clinical Excellence</collab>
</person-group>
<source>The Guidelines Manual</source>
<year>2012</year>
<publisher-loc>London</publisher-loc>
<publisher-name>National Clinical Guideline Centre</publisher-name>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Irving</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Baliunas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roerecke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Patra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mohapatra</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis</article-title>
<source>Addiction</source>
<year>2009</year>
<volume>104</volume>
<fpage>1981</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2009.02694.x</pub-id>
<pub-id pub-id-type="pmid">19804464</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briasoulis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Messerli</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis</article-title>
<source>J Clin Hypertens</source>
<year>2012</year>
<volume>14</volume>
<fpage>792</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/jch.12008</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Keefe</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Bhatti</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Bajwa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>DiNicolantonio</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Alcohol and cardiovascular health: the dose makes the poison…or the remedy</article-title>
<source>Mayo Clin Proc</source>
<year>2014</year>
<volume>89</volume>
<fpage>382</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.mayocp.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24582196</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puddey</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Beilin</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Alcohol is bad for blood pressure</article-title>
<source>Clin Exp Pharmacol Physiol</source>
<year>2006</year>
<volume>33</volume>
<fpage>847</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1681.2006.04452.x</pub-id>
<pub-id pub-id-type="pmid">16922819</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Klatsky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gunderson</surname>
<given-names>E</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Mohler</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Townsend</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Alcohol and hypertension</article-title>
<source>Advanced Therapy in Hypertension and Vascular Disease</source>
<year>2006</year>
<publisher-loc>Hamilton</publisher-loc>
<publisher-name>BC Decker Inc.</publisher-name>
<fpage>108</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sesso</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Buring</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Manson</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Gaziano</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Alcohol consumption and the risk of hypertension in women and men</article-title>
<source>Hypertension</source>
<year>2008</year>
<volume>51</volume>
<fpage>1080</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.104968</pub-id>
<pub-id pub-id-type="pmid">18259032</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klatsky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gundersen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kipp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Udaltsova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>GD</given-names>
</name>
</person-group>
<article-title>Higher prevalence of systemic HTN among moderate alcohol drinkers: exploring the role of under-reporting</article-title>
<source>J Stud Alcohol</source>
<year>2006</year>
<volume>67</volume>
<fpage>421</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.15288/jsa.2006.67.421</pub-id>
<pub-id pub-id-type="pmid">16608152</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Paton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Beevers</surname>
<given-names>DG</given-names>
</name>
</person-group>
<article-title>Alcohol-induced hypertension</article-title>
<source>Lancet</source>
<year>1981</year>
<volume>2</volume>
<fpage>653</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(81)90995-8</pub-id>
<pub-id pub-id-type="pmid">6116043</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Allamani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elekes</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jakubczyk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Landsmane</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>General practitioners recognizing alcohol dependence: a large cross-sectional study in six European countries</article-title>
<source>Ann Fam Med</source>
<year>2015</year>
<volume>13</volume>
<fpage>28</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1370/afm.1742</pub-id>
<pub-id pub-id-type="pmid">25583889</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gmel</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Gmel</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>OSM</given-names>
</name>
<name>
<surname>Imtiaz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Popova</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The relationship between different dimensions of alcohol use and the burden of disease - an update</article-title>
<source>Addiction</source>
<year>2017</year>
<volume>112</volume>
<issue>6</issue>
<fpage>968</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1111/add.13757</pub-id>
<pub-id pub-id-type="pmid">28220587</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Alcohol: an important cause of hypertension</article-title>
<source>BMJ</source>
<year>1987</year>
<volume>294</volume>
<fpage>1045</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.294.6579.1045</pub-id>
<pub-id pub-id-type="pmid">3107685</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baliunas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Borges</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Irving</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Kehoe</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The relation between different dimensions of alcohol consumption and burden of disease - An overview</article-title>
<source>Addiction</source>
<year>2010</year>
<volume>105</volume>
<fpage>817</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2010.02899.x</pub-id>
<pub-id pub-id-type="pmid">20331573</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frontini</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Ogden</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Motsamai</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Whelton</surname>
<given-names>PK</given-names>
</name>
</person-group>
<article-title>Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials</article-title>
<source>Hypertension</source>
<year>2001</year>
<volume>38</volume>
<fpage>1112</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1161/hy1101.093424</pub-id>
<pub-id pub-id-type="pmid">11711507</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Latham</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study</article-title>
<source>Addiction</source>
<year>2008</year>
<volume>103</volume>
<fpage>1622</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.2008.02317.x</pub-id>
<pub-id pub-id-type="pmid">18821872</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roerecke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kaczorowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tobe</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Gmel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>OSM</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis of trial data</article-title>
<source>Lancet Public Health</source>
<year>2016</year>
<volume>2</volume>
<fpage>e108</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/S2468-2667(17)30003-8</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Higgins</surname>
<given-names>JPT</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>S</given-names>
</name>
</person-group>
<source>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration</source>
<year>2011</year>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ozdemir</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Krum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation</article-title>
<source>Hypertension</source>
<year>2015</year>
<volume>65</volume>
<fpage>401</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.04640</pub-id>
<pub-id pub-id-type="pmid">25403604</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mancia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fagard</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Narkiewicz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Redon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zanchetti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bohm</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)</article-title>
<source>J Hypertens</source>
<year>2013</year>
<volume>31</volume>
<fpage>1281</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1097/01.hjh.0000431740.32696.cc</pub-id>
<pub-id pub-id-type="pmid">23817082</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Ashley</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Carruthers</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Lacourcière</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada</article-title>
<source>Can Med Assoc J</source>
<year>1999</year>
<volume>160</volume>
<fpage>S13</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">10333849</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>National Clinical Guideline Centre</collab>
</person-group>
<source>Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34</source>
<year>2011</year>
<publisher-loc>London</publisher-loc>
<publisher-name>Royal College of Physicians (UK) - National Clinical Guideline Centre</publisher-name>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Schiffrin</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>White</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lindholm</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Kenerson</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension</article-title>
<source>J Hypertens</source>
<year>2014</year>
<volume>32</volume>
<fpage>3</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1097/HJH.0000000000000065</pub-id>
<pub-id pub-id-type="pmid">24270181</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Oparil</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Cushman</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Dennison-Himmelfarb</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Handler</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)</article-title>
<source>JAMA</source>
<year>2014</year>
<volume>311</volume>
<fpage>507</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2013.284427</pub-id>
<pub-id pub-id-type="pmid">24352797</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckel</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Jakicic</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ard</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>de Jesus</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Houston Miller</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hubbard</surname>
<given-names>VS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines</article-title>
<source>J Am Coll Cardiol</source>
<year>2014</year>
<volume>63</volume>
<fpage>2960</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2013.11.003</pub-id>
<pub-id pub-id-type="pmid">24239922</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marmet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nutt</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Defining substance use disorders: do we really need more than heavy use?</article-title>
<source>Alcohol Alcohol</source>
<year>2013</year>
<volume>48</volume>
<fpage>633</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agt127</pub-id>
<pub-id pub-id-type="pmid">23926213</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>TK</given-names>
</name>
</person-group>
<article-title>Quantifying the risk for alcohol-use and alcohol-attributable health disorders: present findings and future research needs</article-title>
<source>J Gastroenterol Hepatol</source>
<year>2008</year>
<volume>23</volume>
<fpage>S2</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1746.2007.05298.x</pub-id>
<pub-id pub-id-type="pmid">18336658</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klatsky</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Koplik</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gunderson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kipp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>GD</given-names>
</name>
</person-group>
<article-title>Sequelae of systemic hypertension in alcohol abstainers, light drinkers, and heavy drinkers</article-title>
<source>Am J Cardiol</source>
<year>2006</year>
<volume>98</volume>
<fpage>1063</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjcard.2006.05.029</pub-id>
<pub-id pub-id-type="pmid">17027572</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Egan</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Excessive alcohol consumption and hypertension: clinical implications of current research</article-title>
<source>J Clin Hypertens</source>
<year>2005</year>
<volume>7</volume>
<fpage>346</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1111/j.1524-6175.2004.04463.x</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jakubczyk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pieper</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Struzzo</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol use disorders in Europe: a comparison of general population and primary health care prevalence rates</article-title>
<source>J Subst Use</source>
<year>2016</year>
<volume>21</volume>
<fpage>478</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.3109/14659891.2015.1063719</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Allamani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Elekes</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jakubczyk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol dependence and treatment utilization in Europe - a representative cross-sectional study in primary care</article-title>
<source>BMC Fam Prac</source>
<year>2015</year>
<volume>16</volume>
<fpage>90</fpage>
<pub-id pub-id-type="doi">10.1186/s12875-015-0308-8</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Struzzo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wojnar</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Who receives treatment for alcohol use disorders in the European Union? A cross-sectional representative study in primary and specialized health care</article-title>
<source>Euro Psych</source>
<year>2015</year>
<volume>30</volume>
<fpage>885</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.eurpsy.2015.07.012</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaner</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dickinson</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Pienaar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effectiveness of brief alcohol interventions in primary care populations</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2007</year>
<volume>18</volume>
<fpage>CD004148</fpage>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Wilbourne</surname>
<given-names>PL</given-names>
</name>
</person-group>
<article-title>Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders</article-title>
<source>Addiction</source>
<year>2002</year>
<volume>97</volume>
<fpage>265</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1046/j.1360-0443.2002.00019.x</pub-id>
<pub-id pub-id-type="pmid">11964100</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence</article-title>
<source>Can J Psychiatry</source>
<year>2012</year>
<volume>57</volume>
<fpage>350</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1177/070674371205700604</pub-id>
<pub-id pub-id-type="pmid">22682572</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bladström</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Torup</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van den Brink</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene</article-title>
<source>Biol Psychiat</source>
<year>2013</year>
<volume>73</volume>
<fpage>706</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2012.10.020</pub-id>
<pub-id pub-id-type="pmid">23237314</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Torup</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Van Den Brink</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>K</given-names>
</name>
<collab>ESENSE 2 Study Group</collab>
</person-group>
<article-title>A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence</article-title>
<source>Eur Neuropsychopharmacol</source>
<year>2013</year>
<volume>23</volume>
<fpage>1432</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2013.02.006</pub-id>
<pub-id pub-id-type="pmid">23562264</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Brink</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Torup</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<collab>SENSE Study Group</collab>
</person-group>
<article-title>Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study</article-title>
<source>J Psychopharmacol</source>
<year>2014</year>
<volume>28</volume>
<fpage>733</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1177/0269881114527362</pub-id>
<pub-id pub-id-type="pmid">24671340</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Alcohol screening and alcohol interventions among patients with hypertension in primary health care: An empirical survey of German general practitioners</article-title>
<source>Addict Res Theory</source>
<year>2017</year>
<volume>25</volume>
<issue>4</issue>
<fpage>285</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1080/16066359.2016.1263728</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bendtsen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Drummond</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial</article-title>
<source>Addiction</source>
<year>2016</year>
<volume>111</volume>
<fpage>1935</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1111/add.13476</pub-id>
<pub-id pub-id-type="pmid">27237081</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guillaume</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Goyder</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence</article-title>
<source>J Public Health</source>
<year>2011</year>
<volume>33</volume>
<fpage>412</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1093/pubmed/fdq095</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wojnar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jakubczyk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sovinova</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Managing alcohol problems in general practice in Europe: results from the European ODHIN survey of general practitioners</article-title>
<source>Alcohol Alcohol</source>
<year>2014</year>
<volume>49</volume>
<fpage>531</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agu043</pub-id>
<pub-id pub-id-type="pmid">25031247</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swales</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Guidelines on guidelines</article-title>
<source>J Hypertens</source>
<year>1993</year>
<volume>11</volume>
<fpage>899</fpage>
<lpage>903</lpage>
<pub-id pub-id-type="doi">10.1097/00004872-199309000-00003</pub-id>
<pub-id pub-id-type="pmid">8254172</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure</collab>
</person-group>
<article-title>The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V)</article-title>
<source>Arch Intern Med</source>
<year>1993</year>
<volume>153</volume>
<fpage>154</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1001/archinte.1993.00410020010002</pub-id>
<pub-id pub-id-type="pmid">8422206</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Ezzati</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>CJL</given-names>
</name>
</person-group>
<source>Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors</source>
<year>2004</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>WHO</publisher-name>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Imtiaz</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A narrative review of alcohol consumption as a risk factor for global burden of disease</article-title>
<source>Subst Abuse Treat Prev Policy</source>
<year>2016</year>
<volume>11</volume>
<fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/s13011-016-0081-2</pub-id>
<pub-id pub-id-type="pmid">27793173</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Donnell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Newbury-Birch</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reimer</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews</article-title>
<source>Alcohol Alcohol</source>
<year>2014</year>
<volume>49</volume>
<fpage>66</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agt170</pub-id>
<pub-id pub-id-type="pmid">24232177</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Patra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Popova</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Alcohol drinking cessation and its effect on oesophageal and head and neck cancers: a pooled analysis</article-title>
<source>Int J Cancer</source>
<year>2007</year>
<volume>121</volume>
<fpage>1132</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.22798</pub-id>
<pub-id pub-id-type="pmid">17487833</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The temporal relationship between per capita alcohol consumption and harm: a systematic review of time lag specifications in aggregate time series analyses</article-title>
<source>Drug Alcohol Depend</source>
<year>2012</year>
<volume>123</volume>
<fpage>7</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2011.12.005</pub-id>
<pub-id pub-id-type="pmid">22197480</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zatonski</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sulkowska</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Manczuk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lowenfels</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>La Vecchia</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Liver cirrhosis mortality in Europe, with special attention to central and eastern Europe</article-title>
<source>Eur Addict Res</source>
<year>2010</year>
<volume>16</volume>
<fpage>193</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1159/000317248</pub-id>
<pub-id pub-id-type="pmid">20606444</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Piper</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Burda</surname>
<given-names>BU</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews</article-title>
<source>Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the US Preventive Services Task Force</source>
<year>2014</year>
<publisher-loc>Rockville</publisher-loc>
<publisher-name>Agency for Healthcare Research and Quality</publisher-name>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>U.S. Preventive Services Task Force</collab>
</person-group>
<article-title>Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement</article-title>
<source>Ann Intern Med</source>
<year>2007</year>
<volume>147</volume>
<fpage>783</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-147-11-200712040-00009</pub-id>
<pub-id pub-id-type="pmid">18056662</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheridan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pignone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Donahue</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force</article-title>
<source>Am J Prev Med</source>
<year>2003</year>
<volume>25</volume>
<fpage>151</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/S0749-3797(03)00121-1</pub-id>
<pub-id pub-id-type="pmid">12880884</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaczorowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Dolovich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Karwalajtys</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gierman</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)</article-title>
<source>BMJ</source>
<year>2011</year>
<volume>342</volume>
<fpage>d442</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.d442</pub-id>
<pub-id pub-id-type="pmid">21300712</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodgkinson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mant</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hobbs</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Deeks</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review</article-title>
<source>BMJ</source>
<year>2011</year>
<volume>342</volume>
<fpage>d3621</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.d3621</pub-id>
<pub-id pub-id-type="pmid">21705406</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>National Institute for Health and Clinical Excellence</collab>
</person-group>
<source>Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence</source>
<year>2011</year>
<publisher-loc>London</publisher-loc>
<publisher-name>NICE</publisher-name>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Copello</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hull</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Assessment and management of alcohol use disorders</article-title>
<source>BMJ</source>
<year>2015</year>
<volume>350</volume>
<fpage>h715</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.h715</pub-id>
<pub-id pub-id-type="pmid">25698774</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spithoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kahan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect</article-title>
<source>Can Fam Physician</source>
<year>2015</year>
<volume>61</volume>
<fpage>515</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="pmid">26071155</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shield</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Struzzo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wojnar</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol use disorders in primary health care – what do we know and where do we go?</article-title>
<source>Alcohol Alcohol</source>
<year>2015</year>
<volume>51</volume>
<fpage>422</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agv127</pub-id>
<pub-id pub-id-type="pmid">26574600</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rösner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hackl-Herrwerth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leucht</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vecchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Srisurapanont</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Soyka</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Opioid antagonists for alcohol dependence</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2010</year>
<volume>12</volume>
<fpage>CD001867</fpage>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kresina</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Campopiano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lubran</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>HW</given-names>
</name>
</person-group>
<article-title>Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care</article-title>
<source>Biomed Res Int</source>
<year>2015</year>
<volume>2015</volume>
<fpage>137020</fpage>
<pub-id pub-id-type="pmid">25629034</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baros</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Latham</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Anton</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment</article-title>
<source>Alcohol Alcohol</source>
<year>2008</year>
<volume>43</volume>
<fpage>192</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agm156</pub-id>
<pub-id pub-id-type="pmid">18039674</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguilera</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>De la Sierra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coca</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Effect of alcohol abstinence on blood pressure</article-title>
<source>Hypertension</source>
<year>1999</year>
<volume>33</volume>
<fpage>653</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1161/01.HYP.33.2.653</pub-id>
<pub-id pub-id-type="pmid">10024322</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption</article-title>
<source>BMJ</source>
<year>1988</year>
<volume>297</volume>
<fpage>663</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.297.6649.663</pub-id>
<pub-id pub-id-type="pmid">3052668</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gual</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marmet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Room</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013)</article-title>
<source>Alcohol Alcohol</source>
<year>2014</year>
<volume>49</volume>
<fpage>118</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1093/alcalc/agt171</pub-id>
<pub-id pub-id-type="pmid">24226811</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>European Medicines Agency</collab>
</person-group>
<source>Guideline on the Development of Medicinal Products for the Treatment of Alcohol Dependence</source>
<year>2010</year>
<publisher-loc>London</publisher-loc>
<publisher-name>European Medicines Agency</publisher-name>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarafidis</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Georgianos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bakris</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Resistant hypertension--its identification and epidemiology</article-title>
<source>Nat Rev Nephrol</source>
<year>2013</year>
<volume>9</volume>
<fpage>51</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/nrneph.2012.260</pub-id>
<pub-id pub-id-type="pmid">23165303</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calhoun</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Textor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Toto</surname>
<given-names>RD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research</article-title>
<source>Circulation</source>
<year>2008</year>
<volume>117</volume>
<fpage>e510</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.189141</pub-id>
<pub-id pub-id-type="pmid">18574054</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denolle</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chamontin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Doll</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fauvel</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Girerd</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Herpin</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology</article-title>
<source>Presse Med</source>
<year>2014</year>
<volume>43</volume>
<fpage>1325</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.lpm.2014.07.016</pub-id>
<pub-id pub-id-type="pmid">25459067</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Organisation for Economic Co-operation and Development</collab>
</person-group>
<source>Tackling Harmful Alcohol Use: Economics and Public Health Policy</source>
<year>2015</year>
<publisher-loc>Paris</publisher-loc>
<publisher-name>Organisation for Economic Co-operation and Development</publisher-name>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angus</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Latimer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Preston</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Purshouse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>What are the implications for policy makers? A systematic review of the cost-effectiveness of screening and brief interventions for alcohol misuse in primary care</article-title>
<source>Front Psychiatry</source>
<year>2014</year>
<volume>5</volume>
<fpage>114</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00114</pub-id>
<pub-id pub-id-type="pmid">25225487</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angus</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Estimating the cost-effectiveness of brief interventions for heavy drinking in primary health care across Europe</article-title>
<source>Eur J Public Health</source>
<year>2017</year>
<volume>27</volume>
<issue>2</issue>
<fpage>345</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="pmid">27558943</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Shield</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Rylett</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>
<source>ublic health successes and missed opportunities, Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014</source>
<year>2016</year>
<publisher-loc>Copenhagen</publisher-loc>
<publisher-name>WHO European Region</publisher-name>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Drummond</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Sculpher</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Torrance</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Stoddart</surname>
<given-names>GL</given-names>
</name>
</person-group>
<source>Methods for the Economic Evaluation of Health Care Programmes</source>
<year>2005</year>
<edition>3</edition>
<publisher-loc>New York</publisher-loc>
<publisher-name>Oxford University Press</publisher-name>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banegas</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Graciani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de la Cruz-Troca</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>León-Muñoz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Guallar-Castillón</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Coca</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study</article-title>
<source>Hypertension</source>
<year>2012</year>
<volume>60</volume>
<fpage>898</fpage>
<lpage>905</lpage>
<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.112.193078</pub-id>
<pub-id pub-id-type="pmid">22949530</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godet-Thobie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vernay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noukpoape</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salanave</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Malon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Castebon</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Niveau tensionnel moyen et prévalence de l’hypertension artérielle chez les adultes de 18 à 74 ans, ENNS 2006-2007</article-title>
<source>BEH Thématique</source>
<year>2008</year>
<volume>49-50</volume>
<fpage>478</fpage>
<lpage>83</lpage>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuhauser</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thamm</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ellert</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Blutdruck in Deutschland 2008-2011. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1)</article-title>
<source>Bundesgesundheitsbl</source>
<year>2013</year>
<volume>56</volume>
<fpage>795</fpage>
<lpage>801</lpage>
<pub-id pub-id-type="doi">10.1007/s00103-013-1669-6</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Brien</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Petrie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Littler</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>de Swiet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Padfield</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices</article-title>
<source>J Hypertens</source>
<year>1993</year>
<volume>11</volume>
<fpage>S43</fpage>
<lpage>63</lpage>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>CNESPS - Instituto Superiore di Sanita</collab>
</person-group>
<source>Epidemiology and prevention of cerebrovascular and cardiovascular diseases</source>
<year>2015</year>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bianchini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brignoli</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cricelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cricelli</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Giustini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Medea</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<source>Health Search - Instituto di Ricerca Della SIMG</source>
<year>2014</year>
<publisher-loc>Firenze</publisher-loc>
<publisher-name>Società Italiana di Medicina Generale e delle Cure Primarie</publisher-name>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrario</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chiodini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chambless</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Cesana</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vanuzzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Panico</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation</article-title>
<source>Int J Epidemiol</source>
<year>2005</year>
<volume>34</volume>
<fpage>413</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1093/ije/dyh405</pub-id>
<pub-id pub-id-type="pmid">15659467</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llisterri</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rodriguez-Roca</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alonso-Moreno</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Prieto</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Barrios</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Treatment and blood pressure control in Spain during 2002-2010</article-title>
<source>J Hypertens</source>
<year>2012</year>
<volume>30</volume>
<fpage>2425</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1097/HJH.0b013e3283592583</pub-id>
<pub-id pub-id-type="pmid">22990354</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catalá-López</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ridao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanfélix-Gimeno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Peiró</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Trends of uncontrolled blood pressure in Spain: an updated meta-regression analysis</article-title>
<source>J Hypertens</source>
<year>2013</year>
<volume>31</volume>
<fpage>630</fpage>
<lpage>1</lpage>
<pub-id pub-id-type="doi">10.1097/HJH.0b013e32835c6d19</pub-id>
<pub-id pub-id-type="pmid">23615217</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joffres</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Falaschetti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Robitaille</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Loustalot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Poulter</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study</article-title>
<source>BMJ Open</source>
<year>2013</year>
<volume>3</volume>
<fpage>e003423</fpage>
<pub-id pub-id-type="doi">10.1136/bmjopen-2013-003423</pub-id>
<pub-id pub-id-type="pmid">23996822</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<mixed-citation publication-type="other">Rehm J, Manthey J, Gual A, Wojnar M. Alcohol Dependence in Primary and Specialist Care in Europe - Data set. figshare.
<ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.6084/m9.figshare.2069585.v5">https://dx.doi.org/10.6084/m9.figshare.2069585.v5</ext-link>
. Accessed 7 October 2016.</mixed-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pater</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The Blood Pressure “Uncertainty Range” - a pragmatic approach to overcome current diagnostic uncertainties (II)</article-title>
<source>Curr Control Trials Cardiovasc Med</source>
<year>2005</year>
<volume>6</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/1468-6708-6-5</pub-id>
<pub-id pub-id-type="pmid">15813971</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laatikainen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jula</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kastarinen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salomaa</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Borodulin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Harald</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Verenpainetasot ja hoitotasapaino FINRISKI-tutkimusaluiella 1982-2012 [Blood pressure levels and therapeutic balance in FINRISK study areas in 1982-2012]</article-title>
<source>Suomen Laakarilehti</source>
<year>2013</year>
<volume>68</volume>
<fpage>1803</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Koskinen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lundqvist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ristiluoma</surname>
<given-names>N</given-names>
</name>
</person-group>
<source>Terveys, toimintakysky ja hyvinvointi Suomessa 2011</source>
<year>2012</year>
<publisher-loc>Tampere</publisher-loc>
<publisher-name>Juvenes Print - Suomen Yliopistopaino Oy</publisher-name>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>Global Health Estimates (GHE)</source>
<year>2016</year>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Quantifying the burden of disease: the technical basis for disability-adjusted life years</article-title>
<source>Bull World Health Organ</source>
<year>1994</year>
<volume>72</volume>
<issue>3</issue>
<fpage>429</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="pmid">8062401</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>WHO Department of Information, Evidence and Research</collab>
</person-group>
<source>WHO methods and data sources for global burden of disease estimates 2000-2015</source>
<year>2017</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>WHO</publisher-name>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<mixed-citation publication-type="other">Rehm J, Gmel G, Sierra C, Gual A. Reduction of mortality following better detection of hypertension and alcohol problems in primary health care in Spain. Adicciones. 2016. Ahead of print.</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B08 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000B08 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:5618725
   |texte=   Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:28954635" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024